image_name stringlengths 68 68 | type stringclasses 2
values | gt_table stringlengths 116 12.6k | table_fragment_1 stringlengths 43 8.42k | table_fragment_2 stringlengths 39 8.21k |
|---|---|---|---|---|
7721254c541eb81d5c2e852a15735d41a64ef0a5a8041451fc85950c0945657f.png | complex | <table><tr><td></td><td colspan="4">All subjects</td><td colspan="2">Placebo</td><td colspan="2">Donation</td></tr><tr><td></td><td colspan="2">Group</td><td colspan="2">Time</td><td colspan="2">Time</td><td colspan="2">Time</td></tr><tr><td></td><td><i>F</i> value</td><td><i>p</i> value</td><td><i>F</i> value</td><td>... | <table><tr><td></td><td colspan="4">All subjects</td><td colspan="2">Placebo</td><td colspan="2">Donation</td></tr><tr><td></td><td colspan="2">Group</td><td colspan="2">Time</td><td colspan="2">Time</td><td colspan="2">Time</td></tr><tr><td></td><td>F value</td><td>p value</td><td>F value</td><td>p value</td><td>F val... | <table><tr><td></td><td colspan="4">All subjects</td><td colspan="2">Placebo</td><td colspan="2">Donation</td></tr><tr><td></td><td colspan="2">Group</td><td colspan="2">Time</td><td colspan="2">Time</td><td colspan="2">Time</td></tr><tr><td></td><td>F value</td><td>p value</td><td>F value</td><td>p value</td><td>F val... |
5a5c575650d048316cf56bdf6c883c4167d218a95407a07073e59a2692969e91.png | complex | <table><tr><td></td><td></td><td colspan="2">Number of resting follicles (%)</td><td colspan="2">Number of primary follicles (%)</td><td colspan="2">Number of secondary follicles (%)</td></tr><tr><td>Group</td><td>Total number of follicles</td><td>Total</td><td>Intact</td><td>Total</td><td>Intact</td><td>Total</td><td>... | <table><tr><td></td><td></td><td>Number of resting follicles (%)</td></tr><tr><td>Group</td><td>Total number of follicles</td><td>Total</td></tr><tr><td>Unfrozen</td><td>249</td><td>203 (81.5 %)</td></tr><tr><td>Vitrification</td><td>482</td><td>467*** (96.9 %)</td></tr><tr><td>Slow-freezing</td><td>374</td><td>365*** ... | <table><tr><td>Number of resting follicles (%)</td><td colspan="2">Number of primary follicles (%)</td><td colspan="2">Number of secondary follicles (%)</td></tr><tr><td>Intact</td><td>Total</td><td>Intact</td><td>Total</td><td>Intact</td></tr><tr><td>203 (100 %)</td><td>39 (15.7 %)</td><td>38 (97.4 %)</td><td>7 (2.8 %... |
7c99ef38c018db2f6815f0a766d6e550bfb2369f560f976f9f05475ad366c831.png | complex | <table><tr><td></td><td>Average annual costs</td><td>References</td></tr><tr><td colspan="3">Health care costs (per episode/year)</td></tr><tr><td> Myocardial infarction</td><td>$18627</td><td>Bergenheim et al., 2012 [12]</td></tr><tr><td> Heart failure</td><td>$14118</td><td>Bergenheim et al., 2012 [12]</td></tr><tr><... | <table><tr><td></td><td>Average annual costs</td><td>References</td></tr><tr><td colspan="3">Health care costs (per episode/year)</td></tr><tr><td>Myocardial infarction</td><td>$18627</td><td>Bergenheim et al., 2012 [12]</td></tr><tr><td>Heart failure</td><td>$14118</td><td>Bergenheim et al., 2012 [12]</td></tr><tr><td... | <table><tr><td>Metformin, generic drug</td><td>$24</td><td>NADAC (January 2015) [22]</td></tr><tr><td>Dipeptidyl peptidase-4 inhibitor, brand</td><td>$3500 ($3401; $3599)</td><td>NADAC (January 2015) [22]</td></tr><tr><td>Sulfonylurea (glipizide), generic</td><td>$16</td><td>NADAC (January 2015) [22]</td></tr><tr><td>I... |
65774c26679bfc5425069c62db335b90d28beb3fd43c6a64b9232a265b9e2f12.png | complex | <table><tr><td rowspan="2">Nutrients</td><td rowspan="2">Incomes (€) per Person per Month</td><td colspan="5">Primary</td><td colspan="5">Secondary</td><td colspan="5">Undergraduate</td><td colspan="5">Postgraduate</td></tr><tr><td>Mean</td><td>SE <sup>5</sup></td><td>Difference with >2700 € <sup>2</sup>... | <table><tr><td rowspan="2">Nutrients</td><td rowspan="2">Incomes (€) per Person per Month</td><td colspan="5">Primary</td><td colspan="5">Secondary</td><td colspan="5">Undergraduate</td><td colspan="5">Postgraduate</td></tr><tr><td>Mean</td><td>SE 5</td><td>Difference with >2700 € 2</td><td>Relative Difference (%) 3</t... | <table><tr><td rowspan="3">Magnesium</td><td>1200–1800</td><td>366.7</td><td>11.5</td><td>35.6</td><td>8.9%</td><td></td><td>368.1</td><td>2.8</td><td>19.4</td><td>5.0%</td><td></td><td>379.5</td><td>3.9</td><td>14.0</td><td>3.6%</td><td></td><td>391.1</td><td>5.1</td><td>13.6</td><td>3.4%</td><td></td></tr><tr><td>180... |
d389760a0860d6a7d2c8864a37e8cec738d54f9e322c239816db9b28d161b5b1.png | simple | <table><tr><td>Items</td><td>Mean</td><td>SD</td><td>Median</td><td>Min</td><td>Max</td><td>Skew</td><td>Kurtosis</td></tr><tr><td>1</td><td>0.89</td><td>0.49</td><td>1</td><td>0</td><td>2</td><td>−0.23</td><td>0.79</td></tr><tr><td>2</td><td>0.39</td><td>0.54</td><td>0</td><td>0</td><td>2</td><td>0.97</td><td>&#... | <table><tr><td>Items</td><td>Mean</td><td>SD</td><td>Median</td><td>Min</td><td>Max</td><td>Skew</td><td>Kurtosis</td></tr><tr><td>1</td><td>0.89</td><td>0.49</td><td>1</td><td>0</td><td>2</td><td>−0.23</td><td>0.79</td></tr><tr><td>2</td><td>0.39</td><td>0.54</td><td>0</td><td>0</td><td>2</td><td>0.97</td><td>−0.14</t... | <table><tr><td>Items</td><td>Mean</td><td>SD</td><td>Median</td><td>Min</td><td>Max</td><td>Skew</td><td>Kurtosis</td></tr><tr><td>12</td><td></td><td>61</td><td>1</td><td>0</td><td></td><td></td><td>−0.63</td></tr><tr><td>13</td><td>0.89</td><td>0.50</td><td>1</td><td>0</td><td>2</td><td>−0.22</td><td>0.76</td></tr><t... |
1d4fec610555fab29b3eca8ef0cc8fa8b3d4e457d4f2307350dc663dd88f591c.png | simple | <table><tr><td></td><td><i>N=</i>55</td></tr><tr><td>Motor score</td><td></td></tr><tr><td> Voluntary movement score [0–20]</td><td>6.33 (5.71)</td></tr><tr><td> Stiffness [0–8]</td><td>2.20 (2.14)</td></tr><tr><td> Chorea [0–16]</td><td>5.19 (4.51)</td></tr><tr><td> Precise movement [0–8]</td><... | <table><tr><td></td><td>N=55</td></tr><tr><td>Motor score</td><td></td></tr><tr><td>Voluntary movement score [0–20]</td><td>6.33 (5.71)</td></tr><tr><td>Stiffness [0–8]</td><td>2.20 (2.14)</td></tr></table> | <table><tr><td></td><td>N=55</td></tr><tr><td>Chorea [0–16]</td><td>5.19 (4.51)</td></tr><tr><td>Precise movement [0–8]</td><td>4.06 (2.46)</td></tr><tr><td>Behavioural score</td><td></td></tr><tr><td>Depression anxiety [0–20]</td><td>9.12 (5.01)</td></tr><tr><td>Temper [0–8]</td><td>2.81 (2.18)</td></tr><tr><td>Psycho... |
400b50155e44e7033977d7a0e589b7e8665b312215a7fc986dd67f51ab4518ab.png | simple | <table><tr><td>Characteristic</td><td><i>N</i></td></tr><tr><td>Gender</td><td> </td></tr><tr><td> Male/female </td><td>33/90</td></tr><tr><td>Age </td><td> </td></tr><tr><td> 21 to 30 y</td><td>22</td></tr><tr><td> 31 to 40 y</td><td>36</td></tr><tr><td> 41 to 50 y</td><td>30</td></tr><tr><td> >50 y</td><td>35</td>... | <table><tr><td>Characteristic</td><td>N</td></tr><tr><td>Gender</td><td></td></tr><tr><td>Male/female</td><td>33/90</td></tr><tr><td></td><td></td></tr></table> | <table><tr><td>Age</td><td></td></tr><tr><td>21 to 30 y</td><td>22</td></tr><tr><td>31 to 40 y</td><td>36</td></tr><tr><td>41 to 50 y</td><td>30</td></tr><tr><td>>50 y</td><td>35</td></tr><tr><td>Years in practice</td><td></td></tr><tr><td><5 y</td><td>19</td></tr><tr><td>5 to 10 y</td><td>21</td></tr><tr><td>11 to 20 ... |
1737004d9086890b79abb277bd7cbcf77189be5ac372bdf9db79531acf6c3c33.png | simple | <table><tr><td>Diagnostic miR(s)</td><td>Disease Setting</td><td>Description</td><td>Reference(s)</td></tr><tr><td>miR-20a, miR-24, miR-25, miR-145, miR-152, miR-199-5p, miR-221, miR-222, miR-223, miR-320</td><td>Lung Cancer</td><td>10 microRNAs were found to have significantly different expression levels in NSCLC seru... | <table><tr><td>Diagnostic miR(s)</td><td>Disease Setting</td><td>Description</td><td>Reference(s)</td></tr></table> | <table><tr><td>miR-20a, miR-24, miR-25, miR-145, miR-152, miR-199-5p, miR-221, miR-222, miR-223, miR-320</td><td>Lung Cancer</td><td>10 microRNAs were found to have significantly different expression levels in NSCLC serum samples compared with the control serum samples.</td><td>[24]</td></tr><tr><td>miR-10b, miR-155, m... |
c736baaf01bc27007cf680600e7337135ddd9d9e3727a91d3146b588fb9f9ea4.png | complex | <table><tr><td>Rank</td><td>GAN</td><td>[3]</td><td colspan="2">Rank</td><td>Gene description</td></tr><tr><td></td><td></td><td></td><td>S2N</td><td>SVM-RFE</td><td></td></tr><tr><td>1</td><td>M27891</td><td>•</td><td>1</td><td>2</td><td>cystatin C (<i>CST3</i>)</td></tr><tr><td>2</td><td>M28130</td><td>•<... | <table><tr><td>Rank</td><td>GAN</td><td>[3]</td><td colspan="2">Rank</td><td>Gene description</td></tr><tr><td></td><td></td><td></td><td>S2N</td><td>SVM-RFE</td><td></td></tr><tr><td>1</td><td>M27891</td><td>•</td><td>1</td><td>2</td><td>cystatin C (CST3)</td></tr><tr><td>2</td><td>M28130</td><td>•</td><td>25</td><td>... | <table><tr><td>8</td><td>D88422</td><td></td><td>3</td><td>8</td><td>cystatin A (CSTA)</td></tr><tr><td>9</td><td>M27783</td><td></td><td>15</td><td>5</td><td>elastase 2, neutrophil (ELA2)</td></tr><tr><td>10</td><td>M96326</td><td>•</td><td>75</td><td>10</td><td>azurocidin 1 (AZU1)</td></tr></table> |
18e5c9a792cac2084bcc8c9fedf4cdb5e30e20347834078b6756c1b724b69527.png | simple | <table><tr><td></td><td>SLD (<i>n</i> = 20)</td><td>HAD (<i>n</i> = 20)</td></tr><tr><td>Body weight (g)</td><td></td><td></td></tr><tr><td>initial</td><td>198 ± 4</td><td>200 ± 5</td></tr><tr><td>1 week</td><td>257 ± 6</td><td>247 ± 6</td></tr><tr><td>6 weeks</td><td>450 ± 10</td><td>438 ±... | <table><tr><td></td><td>SLD (n = 20)</td></tr><tr><td>Body weight (g)</td><td></td></tr><tr><td>initial</td><td>198 ± 4</td></tr><tr><td>1 week</td><td>257 ± 6</td></tr><tr><td>6 weeks</td><td>450 ± 10</td></tr><tr><td>70 days</td><td>525 ± 12</td></tr><tr><td>Food intake (g/kg b.w./day)</td><td></td></tr><tr><td>1st w... | <table><tr><td>HAD (n = 20)</td></tr><tr><td></td></tr><tr><td>200 ± 5</td></tr><tr><td>247 ± 6</td></tr><tr><td>438 ± 10</td></tr><tr><td>498 ± 12</td></tr><tr><td></td></tr><tr><td>122 ± 4</td></tr><tr><td>73 ± 1</td></tr><tr><td>66 ± 1</td></tr></table> |
1c1ca57ae724ee07d46563d63397583c79fb2407c9461e686dc914300ef01383.png | complex | <table><tr><td></td><td rowspan="2">Expression</td><td colspan="3">MAWBP</td></tr><tr><td>Protein</td><td>Positive (%)</td><td>Negative (%)</td><td><i>P-</i>value</td></tr><tr><td>TGF-beta</td><td>Positive</td><td>43/216 (19.9)</td><td>59/216 (27.3)</td><td><0.001</td></tr><tr><td></td><td>Negative</td><td>13/216 (6... | <table><tr><td></td><td rowspan="2">Expression</td></tr><tr><td>Protein</td></tr><tr><td>TGF-beta</td><td>Positive</td></tr><tr><td></td><td>Negative</td></tr><tr><td>E-cadherin</td><td>Positive</td></tr><tr><td></td><td>Negative</td></tr><tr><td>PGC</td><td>Positive</td></tr><tr><td></td><td>Negative</td></tr></table> | <table><tr><td colspan="3">MAWBP</td></tr><tr><td>Positive (%)</td><td>Negative (%)</td><td>P-value</td></tr><tr><td>43/216 (19.9)</td><td>59/216 (27.3)</td><td><0.001</td></tr><tr><td>13/216 (6.0)</td><td>101/216 (46.8)</td><td></td></tr><tr><td>31/208 (14.9</td><td>58/208 (27.9)</td><td>0.026</td></tr><tr><td>25/208 ... |
353569041ad3b6497afc0d440421046861a44d933ca7e8d6923272f1d5517281.png | simple | <table><tr><td>Cpd.</td><td>% inhibition (at 6.25 μg/mL)</td><td>Estimation of MIC<sub>90</sub></td><td>LD<sub>50ip</sub> (mg/kg)</td></tr><tr><td>4a</td><td>100</td><td><6.25</td><td>800</td></tr><tr><td>4b</td><td>61</td><td>>6.25</td><td>650</td></tr><tr><td>4c</td><td>91</td><td><6.25</td><td>180</td>... | <table><tr><td>Cpd.</td><td>% inhibition (at 6.25 μg/mL)</td><td>Estimation of MIC90</td><td>LD50ip (mg/kg)</td></tr><tr><td>4a</td><td>100</td><td><6.25</td><td>800</td></tr><tr><td>4b</td><td>61</td><td>>6.25</td><td>650</td></tr><tr><td>4c</td><td>91</td><td><6.25</td><td>180</td></tr><tr><td></td><td>65</td><td>>6.... | <table><tr><td>4d</td><td></td><td>25</td><td>10</td></tr><tr><td>4e</td><td>15</td><td>>6.25</td><td>>1000</td></tr><tr><td>4f</td><td>0</td><td>>6.25</td><td>410</td></tr><tr><td>4g</td><td>92</td><td><6.25</td><td>>1000</td></tr><tr><td>4h</td><td>96</td><td><6.25</td><td>750</td></tr><tr><td>4i</td><td>ND</td><td>N... |
f0ef75f96a887b972e3fcf8a5661fcf7aafe7621d974a3fc95c89743054d6940.png | simple | <table><tr><td>Sex</td><td>Progesterone (ng/ml)</td><td>Corticosterone (ng/ml)</td><td>IGF-I (ng/ml)</td><td>Testosterone (ng/ml)</td><td>Estradiol (ng/ml)</td></tr><tr><td>Female</td><td>2.74 ± 0.44</td><td>67.87 ± 6.26</td><td>43.33 ± 5.66</td><td>1.98 ± 0.21</td><td>6.43 ± 0.31*</td></tr><tr... | <table><tr><td>Sex</td><td>Progesterone (ng/ml)</td></tr><tr><td>Female</td><td>2.74 ± 0.44</td></tr><tr><td>Male</td><td>2.24 ± 1.61</td></tr></table> | <table><tr><td>Corticosterone (ng/ml)</td><td>IGF-I (ng/ml)</td><td>Testosterone (ng/ml)</td><td>Estradiol (ng/ml)</td></tr><tr><td>67.87 ± 6.26</td><td>43.33 ± 5.66</td><td>1.98 ± 0.21</td><td>6.43 ± 0.31*</td></tr><tr><td>55.95 ± 13.99</td><td>47.92 ± 12.76</td><td>2.93 ± 0.32*</td><td>5.21 ± 0.26</td></tr></table> |
28452fe04424b7a85f4ad0642fca8f79b28b48066d7528dd1fe1ae849777ab6c.png | complex | <table><tr><td>Group</td><td>Description of the group</td><td>Strength</td></tr><tr><td>TM1</td><td>The total number of skills is 2; number of skills of each employee and task is 2.</td><td>The quantum of effort needed in every task is to be equal; each employee has the same contribution of maximum dedication and salar... | <table><tr><td>Group</td><td>Description of the group</td><td>Strength</td></tr><tr><td>TM1</td><td>The total number of skills is 2; number of skills of each employee and task is 2.</td><td>The quantum of effort needed in every task is to be equal; each employee has the same contribution of maximum dedication and salar... | <table><tr><td>M4</td><td>f skills is 10; number of employee skills is 2-3; number of skills required in the task is 4-5.</td><td rowspan="2">ks have the same effort and each employee has maximum dedication and salary.</td></tr><tr><td>TM5</td><td>The amount of skills is 5; number of employee skills is 3-4; number of s... |
bef73fe9b9583b3e5eb965f605f860565b41b9619e6ddf47af4889a0b2caa5e1.png | simple | <table><tr><td></td><td>All</td><td>Males</td><td>Females</td></tr><tr><td>Age</td><td></td><td></td><td></td></tr><tr><td> 20 - 29 years</td><td>104 (23.6%)</td><td>41 (21.8%)</td><td>63 (25.0%)</td></tr><tr><td> 30 - 39 years</td><td>116 (26.4%)</td><td>44 (23.4%)</td><td>72 (28.6%)</td></tr><tr><td> 40 - 49 years</t... | <table><tr><td></td><td>All</td><td>Males</td><td>Females</td></tr><tr><td>Age</td><td></td><td></td><td></td></tr><tr><td>20 - 29 years</td><td>104 (23.6%)</td><td>41 (21.8%)</td><td>63 (25.0%)</td></tr><tr><td>30 - 39 years</td><td>116 (26.4%)</td><td>44 (23.4%)</td><td>72 (28.6%)</td></tr><tr><td>40 - 49 years</td><... | <table><tr><td>2 to 5 hrs</td><td>107 (24.3%)</td><td>63 (33.5%)</td><td>44 (17.5%)</td></tr><tr><td>6 to 9 hrs</td><td>248 (56.4%)</td><td>81 (43.1%)</td><td>167 (66.3%)</td></tr><tr><td>> 9 hrs</td><td>85 (19.3%)</td><td>44 (23.4%)</td><td>41 (16.3%)</td></tr></table> |
4fb4127fa146bf1ace9aec73c4146c2408b37a18678755781a7ec0b5eeb83dba.png | simple | <table><tr><td>Gender</td><td>Age (years)</td><td>Length of diagnosis of hypothyroidism (years)</td></tr><tr><td>Female</td><td>93</td><td>13</td></tr><tr><td>Female</td><td>80</td><td>10</td></tr><tr><td>Male</td><td>84</td><td>Approx. 8</td></tr><tr><td>Female</td><td>82</td><td>24</td></tr><tr><td>Male</td><td>83</t... | <table><tr><td>Gender</td><td>Age (years)</td><td>Length of diagnosis of hypothyroidism (years)</td></tr><tr><td>Female</td><td>93</td><td>13</td></tr><tr><td>Female</td><td>80</td><td>10</td></tr><tr><td>Male</td><td>84</td><td>Approx. 8</td></tr></table> | <table><tr><td>Gender</td><td>Age (years)</td><td>Length of diagnosis of hypothyroidism (years)</td></tr><tr><td>Female</td><td>82</td><td>24</td></tr><tr><td>Male</td><td>83</td><td>15</td></tr><tr><td>Female</td><td>88</td><td>9</td></tr><tr><td>Female</td><td>85</td><td>14</td></tr><tr><td>Female</td><td>80</td><td>... |
1631fa74e7b3d91cd6bca4a25fc2b6d72fddbcb86d4d0a23f21a9eb83947b945.png | simple | <table><tr><td>Abbreviated Trial Name/NCT#</td><td>Phase</td><td>Agent(s)</td><td>Study population</td><td>Expected Primary Endpoint</td></tr><tr><td>NCT01935921</td><td>Ib</td><td>Cetuximab, ipilimumab and IMRT</td><td>stage III-IVaHPV+ OPSCC</td><td>Dose limiting toxicities (DLT)</td></tr><tr><td>RTOG 3504NCT02764593... | <table><tr><td>Abbreviated Trial Name/NCT#</td><td>Phase</td><td>Agent(s)</td><td>Study population</td><td>Expected Primary Endpoint</td></tr><tr><td>NCT01935921</td><td>Ib</td><td>Cetuximab, ipilimumab and IMRT</td><td>stage III-IVaHPV+ OPSCC</td><td>Dose limiting toxicities (DLT)</td></tr><tr><td>RTOG 3504NCT02764593... | <table><tr><td>NCT02777385</td><td>II</td><td>Concurrent vs sequential pembro, cisplatin and IMRT</td><td>stage III-IVbHNSCC</td><td>1 year PFS1 year failure rateAcute toxicity rates</td></tr><tr><td>HN003NCT02775812</td><td>I</td><td>Adjuvant pembro, cisplatin and IMRT</td><td>high risk stage III-IV HSNCC</td><td>DLT<... |
15c8fba76546355d7e0b96d58b7c2b297bfd3368059e9dcf3f0dcfb0932975bb.png | complex | <table><tr><td></td><td></td><td colspan="4"></td><td colspan="2">Decay class</td><td colspan="4"></td></tr><tr><td></td><td></td><td colspan="4">Quaking aspen</td><td colspan="2"></td><td colspan="4">Douglas-fir</td></tr><tr><td>Component</td><td>Comparison</td><td>1</td><td>2</td><td>3</td><td>4</td><td>5</td><td>1</... | <table><tr><td></td><td></td><td colspan="4"></td><td colspan="2">Decay class</td><td colspan="4"></td></tr><tr><td></td><td></td><td colspan="4">Quaking aspen</td><td colspan="2"></td><td colspan="4">Douglas-fir</td></tr><tr><td>Component</td><td>Comparison</td><td>1</td><td>2</td><td>3</td><td>4</td><td>5</td><td>1</... | <table><tr><td></td><td></td><td colspan="4"></td><td colspan="2">Decay class</td><td colspan="4"></td></tr><tr><td></td><td></td><td colspan="4">Quaking aspen</td><td colspan="2"></td><td colspan="4">Douglas-fir</td></tr><tr><td>Component</td><td>Comparison</td><td>1</td><td>2</td><td>3</td><td>4</td><td>5</td><td>1</... |
be5d4717e82e405f544cb54200ece7baf1c0232c58e7214b1d05f0b9d8c5531c.png | complex | <table><tr><td></td><td colspan="2">Intervention</td><td colspan="2">Control</td></tr><tr><td>All costs</td><td>USD</td><td>% total costs</td><td>USD</td><td>% total costs</td></tr><tr><td><i>Personnel</i></td><td><i>87 926</i></td><td><i>58.4</i></td><td><i>56 632</i></td><td><i>60.5</i></td></tr><tr><td> CHWs (salari... | <table><tr><td></td><td colspan="2">Intervention</td><td colspan="2">Control</td></tr><tr><td>All costs</td><td>USD</td><td>% total costs</td><td>USD</td><td>% total costs</td></tr><tr><td>Personnel</td><td>87 926</td><td>58.4</td><td>56 632</td><td>60.5</td></tr><tr><td>CHWs (salaries and incentives)</td><td>10 332</t... | <table><tr><td>Cost to partners</td><td>132 425</td><td>88.0</td><td>85 093</td><td>90.9</td></tr><tr><td>Cost to community</td><td>6 218</td><td>4.1</td><td>3 208</td><td>3.4</td></tr></table> |
22dff048d81b405f5e34b601c880fc5403ba5120068a95278a89f0ff0dfcebc4.png | complex | <table><tr><td rowspan="2">Variables</td><td rowspan="2">No. of <i>E. coli</i> tested</td><td>C No. (%)<sup>a</sup></td><td>OT No. (%)<sup>a</sup></td><td>SXT No. (%)<sup>a</sup></td><td colspan="2">PB No. (%)<sup>b</sup></td><td colspan="3">N No. (%)<sup>c</sup></td></tr><tr><td>S</td><td>S</td><td>S</td><td>S</td><td... | <table><tr><td rowspan="2">Variables</td><td rowspan="2">No. of E. coli tested</td><td>C No. (%)a</td><td>OT No. (%)a</td><td>SXT No. (%)a</td><td colspan="2">PB No. (%)b</td><td colspan="3">N No. (%)c</td></tr><tr><td>S</td><td>S</td><td>S</td><td>S</td><td>R</td><td>S</td><td>I</td><td>R</td></tr><tr><td colspan="10"... | <table><tr><td rowspan="2">Variables</td><td rowspan="2">No. of E. coli tested</td><td>C No. (%)a</td><td>OT No. (%)a</td><td>SXT No. (%)a</td><td colspan="2">PB No. (%)b</td><td colspan="3">N No. (%)c</td></tr><tr><td>S</td><td>S</td><td>S</td><td>S</td><td>R</td><td>S</td><td>I</td><td>R</td></tr><tr><td>Birr 50</td>... |
3982122a3879126e73abeef7d1e6be52728995d39cc742e71ceef57bab17ad23.png | complex | <table><tr><td></td><td>Kegg pathway</td><td>Number of genes</td><td>Fold enrichment</td><td>p value<sup>*</sup></td></tr><tr><td rowspan="5">UP</td><td>Steroid biosynthesis (cholesterol biosynthesis)</td><td>7</td><td>23.8</td><td>1.6E-07</td></tr><tr><td>Insulin signaling pathway</td><td>7</td><td>3.1</td><td>2.3E-02... | <table><tr><td></td><td>Kegg pathway</td><td>Number of genes</td><td>Fold enrichment</td><td>p value*</td></tr><tr><td rowspan="2">U</td><td>Steroid biosynthesis (cholesterol biosynthesis)</td><td>7</td><td>23.8</td><td>1.6E-07</td></tr><tr><td>Ins</td><td></td><td>3</td><td>2.3</td></tr></table> | <table><tr><td rowspan="4">P</td><td>ulin signaling pathway</td><td>7</td><td>.1</td><td>E-02</td></tr><tr><td>Adipocytokine signaling pathway</td><td>5</td><td>5</td><td>1.6E-02</td></tr><tr><td>MAPK signaling pathway</td><td>9</td><td>2.5</td><td>2.4E-02</td></tr><tr><td>Glycolysis / Gluconeogenesis</td><td>4</td><td... |
ecde5feebf764c57601c340a0ba98bbedf94d6bf6b1d12f57999562a2f2be722.png | simple | <table><tr><td>Details</td><td>HR-12 (current study)</td><td>93–11 [2]</td><td>IR-64 [3]</td><td>Kasalath [4]</td><td>Nipponbare [1]</td></tr><tr><td>Subspecies</td><td><i>indica</i></td><td><i>indica</i></td><td><i>indica</i></td><td><i>aus</i></td><td><i>japonica</i></td></tr><tr><td>Sequence depth</td><td>73x ... | <table><tr><td>Details</td><td>HR-12 (current study)</td><td>93–11 [2]</td></tr><tr><td>Subspecies</td><td>indica</td><td>indica</td></tr><tr><td>Sequence depth</td><td>73x (Illumina) and 20x (PacBio)</td><td>4.2x (Sanger) and 36x (Illumina)</td></tr><tr><td>Sequencing technologies</td><td>Illumina and PacBio</td><td>S... | <table><tr><td>IR-64 [3]</td><td>Kasalath [4]</td><td>Nipponbare [1]</td></tr><tr><td>indica</td><td>aus</td><td>japonica</td></tr><tr><td>110x (Illumina)</td><td>6x (Roche 454) and 148X (Illumina)</td><td>6x (Sanger), 62x (Illumina) and 2.57x (Roche 454)</td></tr><tr><td>Illumina</td><td>Illumina and Roche 454</td><td... |
d4d0bfe6a5000584fcd5f1a1d79b93d2ef41867bd4076632c3ba18787c06c7f3.png | simple | <table><tr><td>Location</td><td>Posture</td><td>Interpretation</td></tr><tr><td>None</td><td>None</td><td>No heat imprint found in frame. Due to the lack of heat imprint in frame, neither location nor posture can be identified.</td></tr><tr><td>Bed</td><td>Sitting Laying</td><td>The individual is either sitting up in b... | <table><tr><td>Location</td><td>Posture</td><td>Interpretation</td></tr><tr><td>None</td><td>None</td><td>No heat imprint found in frame. Due to the lack of heat imprint in frame, neither location nor posture can be identified.</td></tr><tr><td>Bed</td><td>Sitting Laying</td><td>The individual is either sitting up in b... | <table><tr><td>Location</td><td>Posture</td><td>Interpretation</td></tr><tr><td>Floor</td><td>Standing Sitting Laying</td><td>The person is either standing on the floor, sitting on the floor, or laying on the floor</td></tr></table> |
8bea36337a24c39f165a250684cb610845c32ad54ce4d4b045ed7376f8e06402.png | complex | <table><tr><td>Groups</td><td>Day post-challenge</td><td> </td><td> </td><td> </td></tr><tr><td> </td><td>7</td><td>17</td><td>21</td><td>28</td></tr><tr><td colspan="5">PCV2 in serum</td></tr><tr><td>Vaccinated group</td><td>3 of 5</td><td>3 of 5</td><td>2 of 5</td><td>0 of 5</td></tr><tr><td>Control group</td><td>5 o... | <table><tr><td>Groups</td><td>Day post-challenge</td><td></td><td></td><td></td></tr><tr><td></td><td>7</td><td>17</td><td>21</td><td>28</td></tr><tr><td colspan="5">PCV2 in serum</td></tr><tr><td>Vaccinated group</td><td>3 of 5</td><td>3 of 5</td><td>2 of 5</td><td>0 of 5</td></tr><tr><td>Control group</td><td>5 of 5<... | <table><tr><td>Control group</td><td>8.31 ± 0.40</td><td>8.41 ± 0.91</td><td>8.77 ± 0.55</td><td>7.72 ± 0.55</td></tr></table> |
799f63d152d839f0cfefc132aea713f4053dfbbe84e8440a240b2ee133bf4584.png | complex | <table><tr><td><i>Manufacturer</i></td><td><i>Model</i></td><td><i>AEC System</i></td><td><i>Number of Times Tested</i></td></tr><tr><td>GE</td><td>Discovery 670<sup>a</sup></td><td rowspan="6">AutomA 3D (AutomA & SmartmA)</td><td>2</td></tr><tr><td>GE</td><td>Discovery 670 Pro<sup>a</sup></td><td>1</td></tr><tr><t... | <table><tr><td>Manufacturer</td><td>Model</td><td>AEC System</td><td>Number of Times Tested</td></tr><tr><td>GE</td><td>Discovery 670a</td><td rowspan="6">AutomA 3D (AutomA & SmartmA)</td><td>2</td></tr><tr><td>GE</td><td>Discovery 670 Proa</td><td>1</td></tr><tr><td>GE</td><td>Discovery 690a</td><td>8</td></tr><tr><td... | <table><tr><td>Siemens</td><td>Emotion 16</td><td></td><td>2</td></tr><tr><td>Siemens</td><td>Sensation 16</td><td></td><td>7</td></tr><tr><td>Siemens</td><td>Sensation 16</td><td>CARE Dose 4D</td><td>5</td></tr><tr><td>Siemens</td><td>Sensation 64</td><td></td><td>6</td></tr><tr><td>Siemens</td><td>Sensation 64</td><t... |
efdf728546d1e1011dd0392e128a6c9dedf499c175bd745fcf99f13c914d553d.png | complex | <table><tr><td> </td><td>Prostatitis</td><td>BPH</td><td>PIN</td><td>PC stage I</td><td>PC stage II</td><td>PC stage III</td><td>PC stage IV</td></tr><tr><td> </td><td>N=342</td><td>N=282</td><td>N=138</td><td>N=332</td><td>N=220</td><td>N=48</td><td>N=16</td></tr><tr><td><i>Albumin</i></td><td> </td><td> </td><td> </t... | <table><tr><td></td><td>Prostatitis</td><td>BPH</td><td>PIN</td><td>PC stage I</td><td>PC stage II</td><td>PC stage III</td><td>PC stage IV</td></tr><tr><td></td><td>N=342</td><td>N=282</td><td>N=138</td><td>N=332</td><td>N=220</td><td>N=48</td><td>N=16</td></tr><tr><td>Albumin</td><td></td><td></td><td></td><td></td><... | <table><tr><td>Mean</td><td>426.91</td><td>424.78</td><td>371.84</td><td>404.6</td><td>406.41</td><td>392.11</td><td>393.33</td></tr><tr><td>SD</td><td>375.09</td><td>144.84</td><td>185.54</td><td>155.38</td><td>158.19</td><td>170.98</td><td>73.76</td></tr></table> |
5b2f2e58663bf0b2f3c50a07970775ce64b906b54d3f9964e386d7c7137241dc.png | simple | <table><tr><td></td><td>16-L</td><td>16-O</td><td>32-L</td><td>32-O</td><td>32-LT</td><td>32-OT</td></tr><tr><td></td><td>(n = 8)</td><td>(n = 8)</td><td>(n = 8)</td><td>(n = 8)</td><td>(n = 7)</td><td>(n = 8)</td></tr><tr><td>Body Weight (g)</td><td>383.8 ± 8.9</td><td>468.8 ± 10.6 **</td><td>460.8 ± 7.... | <table><tr><td></td><td>16-L</td><td>16-O</td><td>32-L</td><td>32-O</td><td>32-LT</td><td>32-OT</td></tr><tr><td></td><td>(n = 8)</td><td>(n = 8)</td><td>(n = 8)</td><td>(n = 8)</td><td>(n = 7)</td><td>(n = 8)</td></tr><tr><td>Body Weight (g)</td><td>383.8 ± 8.9</td><td>468.8 ± 10.6 **</td><td>460.8 ± 7.6</td><td>563.2... | <table><tr><td>60 min</td><td>131.1 ± 4.1</td><td>157.1 ± 14.4</td><td>142.5 ± 4.1</td><td>310.7 ± 5.0††</td><td>134.9 ± 1.7</td><td>225.6 ± 6.9##</td></tr><tr><td>120 min</td><td>102.6 ± 4.1</td><td>100.9 ± 1.9</td><td>101.9 ± 1.9</td><td>161.5 ± 4.8††</td><td>95.1 ± 3.1</td><td>98.9 ± 4.3##</td></tr></table> |
0b7ea8b800a624e90e5b4bf257231105d314269447583e741486fa5b2a73b8a3.png | complex | <table><tr><td>Code</td><td>Communication items</td><td colspan="3">Inpatient</td><td colspan="3">Outpatient</td></tr><tr><td> </td><td> </td><td>Explaining</td><td>Breaking bad news</td><td>Discussing with a family</td><td>Explaining a diagnosis</td><td>Managing time</td><td>Managing a difficult consultation</td></tr>... | <table><tr><td>Code</td><td>Communication items</td><td colspan="3">Inpatient</td><td colspan="3">Outpatient</td></tr><tr><td></td><td></td><td>Explaining</td><td>Breaking bad news</td><td>Discussing with a family</td><td>Explaining a diagnosis</td><td>Managing time</td><td>Managing a difficult consultation</td></tr><t... | <table><tr><td>Code</td><td>Communication items</td><td colspan="3">Inpatient</td><td colspan="3">Outpatient</td></tr><tr><td></td><td></td><td>Explaining</td><td>Breaking bad news</td><td>Discussing with a family</td><td>Explaining a diagnosis</td><td>Managing time</td><td>Managing a difficult consultation</td></tr><t... |
8c1caf9ddc5d4cca1642d4a9e8e3e2575db90769cfff8eaea60554535c91466f.png | complex | <table><tr><td rowspan="2">Histopathology</td><td>Pediatrics</td><td>Adults</td><td>All patients</td></tr><tr><td colspan="3">n (%)</td></tr><tr><td>Pineal region tumors</td><td>4 (10)</td><td>2 (5)</td><td>6 (14)</td></tr><tr><td>Colloid cyst</td><td>-</td><td>6 (14)</td><td>6 (14)</td></tr><tr><td>Pilocytic astrocyto... | <table><tr><td rowspan="2">Histopathology</td><td>Pediatrics</td><td>Adults</td></tr><tr><td colspan="2">n (%)</td></tr><tr><td>Pineal region tumors</td><td>4 (10)</td><td>2 (5)</td></tr><tr><td>Colloid cyst</td><td>-</td><td>6 (14)</td></tr><tr><td>Pilocytic astrocytoma</td><td>3 (10)</td><td>2 (5)</td></tr><tr><td>Ce... | <table><tr><td>All patients</td></tr><tr><td>n (%)</td></tr><tr><td>6 (14)</td></tr><tr><td>6 (14)</td></tr><tr><td>5 (12)</td></tr><tr><td>5 (12)</td></tr><tr><td>4 (10)</td></tr><tr><td>3 (7)</td></tr><tr><td>2 (5)</td></tr><tr><td>2 (5)</td></tr><tr><td>1 (2)</td></tr><tr><td>1 (2)</td></tr><tr><td>1 (2)</td></tr><t... |
3b6703e9457a654b6a5ffe37dfb35db09f75e7682181761ff707174fe8160d28.png | simple | <table><tr><td>Visual area</td><td>Raw <i>N</i> PV</td><td>Corrected <i>N</i> PV</td><td>Raw <i>N</i> dual-labeled</td><td>Corrected <i>N</i> dual-labeled</td><td>% dually-labeled</td></tr><tr><td>V1</td><td>293</td><td>205</td><td>235</td><td>164</td><td>80</td></tr><tr><td>MT</td><td>293</td><td>205</td><td>218</td><... | <table><tr><td>Visual area</td><td>Raw N PV</td><td>Corrected N PV</td><td>Raw N dual-labeled</td><td>Corrected N dual-labeled</td><td>% dually-labeled</td></tr></table> | <table><tr><td>V1</td><td>293</td><td>205</td><td>235</td><td>164</td><td>80</td></tr><tr><td>MT</td><td>293</td><td>205</td><td>218</td><td>153</td><td>75</td></tr></table> |
d772bf761858d418c4b0ee3b77c1ed817be88745fcef74de09718eb13df98813.png | simple | <table><tr><td>Variable</td><td>Total of patients or mean value</td></tr><tr><td>Gender</td><td> </td></tr><tr><td> Female </td><td>624 (41,8%)</td></tr><tr><td> Male </td><td>868 (58,2%)</td></tr><tr><td>Gestational age (weeks)</td><td> </td></tr><tr><td> 28</td><td>18 (1,2%)</td></tr><tr><td> [28–32[</td><td>85... | <table><tr><td>Variable</td><td>Total of patients or mean value</td></tr><tr><td>Gender</td><td></td></tr><tr><td>Female</td><td>624 (41,8%)</td></tr><tr><td>Male</td><td>868 (58,2%)</td></tr><tr><td>Gestational age (weeks)</td><td></td></tr><tr><td>28</td><td>18 (1,2%)</td></tr><tr><td>[28–32[</td><td>85 (5,7%)</td></... | <table><tr><td>Variable</td><td>Total of patients or mean value</td></tr><tr><td>eight (g)</td><td></td></tr><tr><td><750</td><td>12 (0,8%)</td></tr><tr><td>[750–1000[</td><td>14 (0,9%)</td></tr><tr><td>[1000–1500[</td><td>72 (4,8%)</td></tr><tr><td>[1500–2500[</td><td>464 (31,1%)</td></tr><tr><td>[2500–4000[</td><td>8... |
6699754b0af133944fe80dc0187b38418d3de0f4da60b49255eb2787dd587950.png | simple | <table><tr><td></td><td><i>Total (£)</i></td></tr><tr><td><i>Trial Website:</i></td><td></td></tr><tr><td>Implementation of the consent process and the randomization and group assignment system</td><td>470</td></tr><tr><td>Implementation of the primary and secondary outcome questionnaires, including the code</td><... | <table><tr><td></td><td>Total (£)</td></tr><tr><td>Trial Website:</td><td></td></tr><tr><td>Implementation of the consent process and the randomization and group assignment system</td><td>470</td></tr><tr><td>Implementation of the primary and secondary outcome questionnaires, including the code</td><td>1,410</td></tr><... | <table><tr><td>Intervention Website:</td><td></td></tr><tr><td>Implementation of the three modules, based on restructuring some old content and adding more new content provided by research team</td><td>5,875</td></tr><tr><td>SUB TOTAL:</td><td>11,045</td></tr><tr><td>Technical consultancy & project management</td><td>7... |
20cbe3917514b3b192d61498d72bf149d2aaba16f0893c7c6821edbf41113af4.png | complex | <table><tr><td></td><td colspan="2"><i>Acinetobacter baumanii</i> (<i>N</i> = 59)</td><td colspan="2"><i>Escherichia coli</i> (<i>N</i> = 92)</td><td colspan="2"><i>Klebsiella pneumoniae</i> (<i>N</i> = 92)</td><td colspan="2"><i>Pseudomonas aeruginosa</i> (<i>N</i> = 26)</td><td colspan="2">Non-typhoidal <i>Salmonella... | <table><tr><td></td><td colspan="2">Acinetobacter baumanii (N = 59)</td><td colspan="2">Escherichia coli (N = 92)</td><td colspan="2">Klebsiella pneumoniae (N = 92)</td><td colspan="2">Pseudomonas aeruginosa (N = 26)</td><td colspan="2">Non-typhoidal Salmonella (N = 20)</td></tr><tr><td>Antimicrobial</td><td>No isolate... | <table><tr><td></td><td colspan="2">Acinetobacter baumanii (N = 59)</td><td colspan="2">Escherichia coli (N = 92)</td><td colspan="2">Klebsiella pneumoniae (N = 92)</td><td colspan="2">Pseudomonas aeruginosa (N = 26)</td><td colspan="2">Non-typhoidal Salmonella (N = 20)</td></tr><tr><td>Antimicrobial</td><td>No isolate... |
3624fa3cdff3989e8b0bc997a4ab590bb177d012fcf56c3c683aa2b770e71a26.png | simple | <table><tr><td>Parameter</td><td>HR point estimate</td><td>95% CI</td><td>p-value</td></tr><tr><td><i>Continuous variables</i></td><td></td><td></td><td></td></tr><tr><td>Age (years)<sup>*</sup></td><td>1.05</td><td>0.81-1.37</td><td>0.722</td></tr><tr><td>Gleason score</td><td>0.82</td><td>0.71-0.96</td><td>0.012</td>... | <table><tr><td>Parameter</td><td>HR point estimate</td><td>95% CI</td><td>p-value</td></tr><tr><td>Continuous variables</td><td></td><td></td><td></td></tr><tr><td>Age (years)*</td><td>1.05</td><td>0.81-1.37</td><td>0.722</td></tr><tr><td>Gleason score</td><td>0.82</td><td>0.71-0.96</td><td>0.012</td></tr></table> | <table><tr><td>Parameter</td><td>HR point estimate</td><td>95% CI</td><td>p-value</td></tr><tr><td>PSA#</td><td>1.00</td><td>0.89-1.13</td><td>0.001</td></tr><tr><td>Linear interaction term with time°</td><td>1.03</td><td>1.01-1.06</td><td></td></tr><tr><td>ALP#</td><td>1.07</td><td>0.99-1.16</td><td>0.074</td></tr><tr... |
57aece16864fb8ee80352ca611c163e3d7564032e457cf31e45ef62e193dc44f.png | simple | <table><tr><td>Statement</td><td>Online simulator superior</td><td>Equivalent</td><td>Atlas or lecture superior</td><td>Unsure</td></tr><tr><td>Learning tympanic membrane anatomy</td><td>45.5%</td><td>45.5%</td><td>0.0%</td><td>9.1%</td></tr><tr><td>Learning external auditory canal anatomy</td><td>63.6%</td><td>36.4%</... | <table><tr><td>Statement</td><td>Online simulator superior</td><td>Equivalent</td><td>Atlas or lecture superior</td><td>Unsure</td></tr><tr><td>Learning tympanic membrane anatomy</td><td>45.5%</td><td>45.5%</td><td>0.0%</td><td>9.1%</td></tr><tr><td>Learning external auditory canal anatomy</td><td>63.6%</td><td>36.4%</... | <table><tr><td>Statement</td><td>Online simulator superior</td><td>Equivalent</td><td>Atlas or lecture superior</td><td>Unsure</td></tr><tr><td>ique</td><td></td><td>27.3%</td><td>0.0%</td><td></td></tr><tr><td>Availability of training technique</td><td>54.5%</td><td>9.1%</td><td>27.3%</td><td>9.1%</td></tr></table> |
2171fcdf2cb2e4b49d2243b4b91aa7ce082bf40a5d93aba6bdba77e56369fee0.png | simple | <table><tr><td>LncRNA name</td><td>Target</td><td>Cell type</td><td>Organism/system</td></tr><tr><td>FAL1</td><td>p21</td><td>Cancer cells</td><td>Human/<i>in vitro</i></td></tr><tr><td>BANCR</td><td>p21</td><td>Colorectal cancer cells</td><td>Human/<i>in vitro</i></td></tr><tr><td>LINCRNA-p21</td><td>p21</td><td>Mouse... | <table><tr><td>LncRNA name</td></tr><tr><td>FAL1</td></tr><tr><td>BANCR</td></tr><tr><td>LINCRNA-p21</td></tr><tr><td>MALAT1</td></tr><tr><td>7SL</td></tr><tr><td>VAD</td></tr><tr><td>ANRIL</td></tr><tr><td>MIR31HG</td></tr><tr><td>UCA1</td></tr><tr><td>SAL-RNA</td></tr><tr><td>SALNR</td></tr><tr><td>TERRA</td></tr><tr... | <table><tr><td>Target</td><td>Cell type</td><td>Organism/system</td></tr><tr><td>p21</td><td>Cancer cells</td><td>Human/in vitro</td></tr><tr><td>p21</td><td>Colorectal cancer cells</td><td>Human/in vitro</td></tr><tr><td>p21</td><td>Mouse embryonic fibroblasts</td><td>Mouse/in vivo and in vitro</td></tr><tr><td>p53</t... |
350d40af7161463f0978853191c8d276c1235ec92f24a5cc97e320321b9ffd8e.png | complex | <table><tr><td></td><td></td><td colspan="4">Proportion of reps. meeting:</td><td></td><td></td><td></td><td></td></tr><tr><td></td><td></td><td colspan="2">Linkage threshold</td><td colspan="2">Association threshold (avg. no. SNPs analyzed)<sup>c</sup></td><td colspan="2">Avg. no. cases analyzed</td><td colspan="2">Ov... | <table><tr><td></td><td></td><td colspan="4">Proportion of reps. meeting:</td><td></td><td></td><td></td><td></td></tr><tr><td></td><td></td><td colspan="2">Linkage threshold</td><td colspan="2">Association threshold (avg. no. SNPs analyzed)c</td><td colspan="2">Avg. no. cases analyzed</td><td colspan="2">Overall power... | <table><tr><td></td><td>E</td><td>0.2</td><td>0.65</td><td>0.30 (48)</td><td>0.20 (148)</td><td>129</td><td>121</td><td>0.06</td><td>0.13</td></tr><tr><td>11 (389)</td><td>A</td><td>0.06</td><td>0.24</td><td>1 (52)</td><td>1 (147)</td><td>1500</td><td>1500</td><td>0.06</td><td>0.24</td></tr><tr><td></td><td>B</td><td>0... |
e0227ea55f077be4deb15311509709e0ab19a31ed373dd03a5c1f8a8b7806e5a.png | complex | <table><tr><td rowspan="2">Exp</td><td rowspan="2">Dilution of 2-butanone (‘X’), %</td><td rowspan="2">N</td><td rowspan="2">n</td><td rowspan="2">%Response</td><td colspan="2">Mean (±SE) mosquito catches</td><td rowspan="2">Exp (B)</td></tr><tr><td>Reference (MB5 + CO<sub>2</sub>)</td><td>Test treatme... | <table><tr><td rowspan="2">Exp</td><td rowspan="2">Dilution of 2-butanone (‘X’), %</td><td rowspan="2">N</td><td rowspan="2">n</td><td rowspan="2">%Response</td><td colspan="2">Mean (±SE) mosquito catches</td><td rowspan="2">Exp (B)</td></tr><tr><td>Reference (MB5 + CO2)</td><td>Test treatment (MB5 + ‘X’)</td></tr><tr>... | <table><tr><td rowspan="2">Exp</td><td rowspan="2">Dilution of 2-butanone (‘X’), %</td><td rowspan="2">N</td><td rowspan="2">n</td><td rowspan="2">%Response</td><td colspan="2">Mean (±SE) mosquito catches</td><td rowspan="2">Exp (B)</td></tr><tr><td>Reference (MB5 + CO2)</td><td>Test treatment (MB5 + ‘X’)</td></tr><tr>... |
d624ca78a9d1c8e4beec5cb38369dde1f6a46d03bb2f8972cc0f736e0b51397a.png | complex | <table><tr><td rowspan="3">CS Diagnostic Kit</td><td colspan="4">Microscopy</td><td colspan="4">PCR</td></tr><tr><td colspan="2"><i>P. falciparum*</i></td><td colspan="2"><i>P. vivax</i></td><td colspan="2"><i>P. falciparum*</i></td><td colspan="2">P.<i>vivax</i></td></tr><tr><td>Positive</td><td>Negative</td><td>Posit... | <table><tr><td>CS Diagnostic Kit</td><td colspan="4">Microscopy</td><td colspan="4">PCR</td></tr></table> | <table><tr><td rowspan="2">CS Diagnostic Kit</td><td colspan="2">P. falciparum*</td><td colspan="2">P. vivax</td><td colspan="2">P. falciparum*</td><td colspan="2">P.vivax</td></tr><tr><td>Positive</td><td>Negative</td><td>Positive</td><td>Negative</td><td>Positive</td><td>Negative</td><td>Positive</td><td>Negative</td... |
9987476d829ac53db1c9545cd4e77c34fbb50415d316e5e3ff1ee2931f141aa1.png | complex | <table><tr><td rowspan="2"></td><td>Resident</td><td>Fellow</td><td>Attending</td><td>Overall</td></tr><tr><td><i>N</i> = 46</td><td><i>N</i> = 36</td><td><i>N</i> = 94</td><td><i>N</i> = 176</td></tr><tr><td>Mean theory of</td><td></td><td></td><td></td><td></td></tr><tr><td>Intelligence score (SD):</td><td>3.66 (1.22... | <table><tr><td></td><td>Resident</td><td>Fellow</td><td>Attending</td><td>Overall</td></tr></table> | <table><tr><td></td><td>N = 46</td><td>N = 36</td><td>N = 94</td><td>N = 176</td></tr><tr><td>Mean theory of</td><td></td><td></td><td></td><td></td></tr><tr><td>Intelligence score (SD):</td><td>3.66 (1.22)</td><td>3.40 (1.15)</td><td>3.66 (1.29)</td><td>3.64 (1.22)</td></tr><tr><td>Fixed (1–3)</td><td>20</td><td>19</t... |
e4bd437832fe05d5a4d815893a6f379a9ba7aaea666b61115beea1e6a970a5e4.png | simple | <table><tr><td>SNP density (k/M)</td><td>WS</td><td>BayesC</td><td>BayesD</td></tr><tr><td>0.5</td><td>0.25</td><td>0.653 (0.223)</td><td>0.639 (0.219)</td></tr><tr><td></td><td>0.5</td><td>1.050 (0.275)</td><td>1.047 (0.245)</td></tr><tr><td></td><td>1</td><td>1.779 (0.283)</td><td>1.796 (0.259)</td></tr><tr><td>1</td... | <table><tr><td>SNP density (k/M)</td><td>WS</td><td>BayesC</td><td>BayesD</td></tr><tr><td>0.5</td><td>0.25</td><td>0.653 (0.223)</td><td>0.639 (0.219)</td></tr><tr><td></td><td>0.5</td><td>1.050 (0.275)</td><td>1.047 (0.245)</td></tr><tr><td></td><td>1</td><td>1.779 (0.283)</td><td>1.796 (0.259)</td></tr><tr><td>1</td... | <table><tr><td>2</td><td>0.25</td><td>0.506 (0.138)</td><td>0.467 (0.085)</td></tr><tr><td></td><td>0.5</td><td>0.930 (0.125)</td><td>0.909 (0.121)</td></tr><tr><td></td><td>1</td><td>1.746 (0.184)</td><td>1.728 (0.157)</td></tr><tr><td>7</td><td>0.25</td><td>0.468 (0.042)</td><td>0.449 (0.046)</td></tr><tr><td></td><t... |
5770e5574a5634f9f3512d897b82da5997ee6c5c1802794e7d4344492730e414.png | simple | <table><tr><td></td><td>ALL</td><td>GIST</td><td>Melanoma</td></tr><tr><td>global-median</td><td>-0.098</td><td>0.344</td><td>-0.751</td></tr><tr><td>popLowess</td><td>-0.239</td><td>0.348</td><td>-0.760</td></tr><tr><td>Chen <i>et al</i>.</td><td>-0.228</td><td>0.315</td><td>-0.508</td></tr><tr><td>CGHnormaliter</td><... | <table><tr><td></td><td>ALL</td><td>GIST</td><td>Melanoma</td></tr><tr><td>g</td><td></td><td>0.34</td><td>-0.751</td></tr></table> | <table><tr><td></td><td>ALL</td><td>GIST</td><td>Melanoma</td></tr><tr><td>lobal-median</td><td>-0.098</td><td>4</td><td></td></tr><tr><td>popLowess</td><td>-0.239</td><td>0.348</td><td>-0.760</td></tr><tr><td>Chen et al.</td><td>-0.228</td><td>0.315</td><td>-0.508</td></tr><tr><td>CGHnormaliter</td><td>-0.204</td><td>... |
eefd013b7e67fa09bd17dbd824a133830c200d8644a524c2ff2801d6f7a21d4c.png | simple | <table><tr><td>Characteristic</td><td></td></tr><tr><td>Age, years</td><td>69.6 ± 17.0<sup>a</sup></td></tr><tr><td>Male sex, no. (%)</td><td>187 (61.9)</td></tr><tr><td>Smoking status</td><td></td></tr><tr><td> Current smoker, no. (%)</td><td>73 (24.2)</td></tr><tr><td> Pack-years for smokers</td><td>40.1 ± ... | <table><tr><td>Characteristic</td><td></td></tr></table> | <table><tr><td>Age, years</td><td>69.6 ± 17.0a</td></tr><tr><td>Male sex, no. (%)</td><td>187 (61.9)</td></tr><tr><td>Smoking status</td><td></td></tr><tr><td>Current smoker, no. (%)</td><td>73 (24.2)</td></tr><tr><td>Pack-years for smokers</td><td>40.1 ± 24.2a</td></tr><tr><td>Antibiotic pretreatment (%)</td><td>61 (2... |
6bffddb1f6a4efb28ddf0dae4d21d0bca91500e29580686df4e6a26820552ecd.png | simple | <table><tr><td>Plants</td><td>Root number (mean ± SE)a</td><td>Root length (cm) (mean ± SE)b</td><td>Dry root biomass (mg) (mean ± SE)b</td><td>Shoot height (cm) (mean ± SE)b</td><td>Dry shoot biomass (mg) (mean ± SE)b</td></tr><tr><td>WT</td><td>4.4 ± 0.5</td><td>28.2 ± 0.7</td><td>5... | <table><tr><td>Plants</td><td>Root number (mean ± SE)a</td><td>Root length (cm) (mean ± SE)b</td><td>Dry root biomass (mg) (mean ± SE)b</td><td>Shoot height (cm) (mean ± SE)b</td><td>Dry shoot biomass (mg) (mean ± SE)b</td></tr><tr><td>WT</td><td>4</td><td>28.2 ± 0</td><td>543.6 ± 14</td><td>4</td><td>3093.4 ± 146.</td... | <table><tr><td></td><td>.4 ± 0.5</td><td>.7</td><td>.6</td><td>8.0 ± 0.9</td><td>1</td></tr><tr><td>iaaM</td><td>13.8 ± 1.1*</td><td>24.5 ± 0.9*</td><td>345.3 ± 23.9*</td><td>46.7 ± 1.5</td><td>2969.5 ± 73.25</td></tr><tr><td>iaaM+CKX</td><td>14.4 ± 1.2*</td><td>33.7 ± 1.0*</td><td>688.3 ± 57.3*</td><td>47.5 ± 1.2</td>... |
8f7cf9b46f627452da1bb4580d5d2dc9efbfb2f8e126151f2c4df749f625da45.png | complex | <table><tr><td>Gene Symbol</td><td>Gene Name</td><td>Entrez Gene ID</td><td>Fold difference DA/Cia5a</td><td>p-value*</td></tr><tr><td> </td><td colspan="4"><i>Anti-inflammatory and regulators of immune responses</i></td></tr><tr><td><i>Scd1</i></td><td>stearoyl-Coenzyme A desaturase 1</td><td>246074</td><td>54.62</td>... | <table><tr><td>Gene Symbol</td><td>Gene Name</td><td>Entrez Gene ID</td></tr><tr><td></td><td colspan="2">Anti-inflammatory and regulators of immune responses</td></tr><tr><td>Scd1</td><td>stearoyl-Coenzyme A desaturase 1</td><td>246074</td></tr><tr><td>Timp3</td><td>TIMP metallopeptidase inhibitor 3</td><td>25358</td>... | <table><tr><td>Fold difference DA/Cia5a</td><td>p-value*</td></tr><tr><td colspan="2">Anti-inflammatory and regulators of immune responses</td></tr><tr><td>54.62</td><td>0.0001</td></tr><tr><td>11.48</td><td>0.000000003</td></tr><tr><td>10.96</td><td>0.000003</td></tr><tr><td>4.18</td><td>0.00002</td></tr><tr><td>3.38<... |
3390399d7c5ec6201ecd48d26c81c5ad19e12b78f63765ffb2015ccf61656d90.png | simple | <table><tr><td>Variable</td><td>Frequency</td><td>Median (IQR) or percentage</td></tr><tr><td><i>Age in years</i></td><td>740</td><td>35 [27–42]</td></tr><tr><td><i>Age group</i></td><td> </td><td> </td></tr><tr><td> ≥45 years</td><td>156</td><td>21.1</td></tr><tr><td> <45 years</td><td>584</td><td>78.9<... | <table><tr><td>Variable</td><td>Frequency</td><td>Median (IQR) or percentage</td></tr><tr><td>Age in years</td><td>740</td><td>35 [27–42]</td></tr><tr><td>Age group</td><td></td><td></td></tr><tr><td>≥45 years</td><td>156</td><td>21.1</td></tr><tr><td><45 years</td><td>584</td><td>78.9</td></tr><tr><td>Sex</td><td></td... | <table><tr><td>Variable</td><td>Frequency</td><td>Median (IQR) or percentage</td></tr><tr><td>Moderate anemia</td><td>88</td><td>11.9</td></tr><tr><td>Severe anemia</td><td>53</td><td>7.2</td></tr><tr><td>OI on diagnosis</td><td></td><td></td></tr><tr><td>Tuberculosis</td><td>197</td><td>26.6</td></tr><tr><td>Others</t... |
7a8840cf47e0cf61ab2a0eaeb9dc8b42564905d198bd7406f5cfbd38e7a4b561.png | complex | <table><tr><td>Strain</td><td colspan="3">AltDE</td><td colspan="3">AltDE1</td></tr><tr><td>Total genes in the genome</td><td colspan="3">4389</td><td colspan="3">4748</td></tr><tr><td>Total core genes in the genome (%)<sup>a</sup></td><td colspan="3">3631 (83)</td><td colspan="3">3631 (76)</td></tr><tr><td>Total flexi... | <table><tr><td>Strain</td><td colspan="3">AltDE</td><td colspan="3">AltDE1</td></tr></table> | <table><tr><td>Total genes in the genome</td><td colspan="3">4389</td><td colspan="3">4748</td></tr><tr><td>Total core genes in the genome (%)a</td><td colspan="3">3631 (83)</td><td colspan="3">3631 (76)</td></tr><tr><td>Total flexible genes in the genome (%)a</td><td colspan="3">758 (17)</td><td colspan="3">1117 (24)<... |
1d42ade7b14fd7ff1005057a6958852077c595c3cbb5ca84ec2f1e7855f2d9f2.png | simple | <table><tr><td>Method</td><td>Specificity</td><td>Recall</td><td>Precision</td><td>F1</td><td>ΔF1</td></tr><tr><td>Robetta</td><td>0.87</td><td>0.33</td><td>0.52</td><td>0.40</td><td>**</td></tr><tr><td>FOLDEF</td><td>0.88</td><td>0.26</td><td>0.48</td><td>0.34</td><td>-0.06</td></tr><tr><td>KFC</td><td>0.85</td><... | <table><tr><td>Method</td></tr><tr><td>Robetta</td></tr><tr><td>FOLDEF</td></tr><tr><td>KFC</td></tr><tr><td>MINERVA</td></tr><tr><td>APIS (this work)</td></tr></table> | <table><tr><td>Specificity</td><td>Recall</td><td>Precision</td><td>F1</td><td>ΔF1</td></tr><tr><td>0.87</td><td>0.33</td><td>0.52</td><td>0.40</td><td>**</td></tr><tr><td>0.88</td><td>0.26</td><td>0.48</td><td>0.34</td><td>-0.06</td></tr><tr><td>0.85</td><td>0.31</td><td>0.48</td><td>0.37</td><td>-0.03</td></tr><tr><t... |
bf24bd850b958bc10b1e912df47d8ac0fda8e7418e73a77a0a13bcfd0f1c97c9.png | simple | <table><tr><td>Food (utensil)</td><td>Accuracy</td></tr><tr><td>Meat (fork and knife)</td><td>127%</td></tr><tr><td>Sides (fork)</td><td>82.6%</td></tr><tr><td>Soup (spoon)</td><td>60.2%</td></tr><tr><td>Pizza (hands)</td><td>87.3%</td></tr><tr><td>Soda (hands)</td><td>81.7%</td></tr><tr><td>Smoothie (straw)</td><td>57... | <table><tr><td>Food (utensil)</td></tr><tr><td>Meat (fork and knife)</td></tr><tr><td>Sides (fork)</td></tr><tr><td>Soup (spoon)</td></tr><tr><td>Pizza (hands)</td></tr><tr><td>Soda (hands)</td></tr><tr><td>Smoothie (straw)</td></tr><tr><td>Total</td></tr></table> | <table><tr><td>Accuracy</td></tr><tr><td>127%</td></tr><tr><td>82.6%</td></tr><tr><td>60.2%</td></tr><tr><td>87.3%</td></tr><tr><td>81.7%</td></tr><tr><td>57.7%</td></tr><tr><td>81.2%</td></tr></table> |
780c0f74f2b73ff131db54b51a25fcdd60865a18462de763642705814cb286d1.png | simple | <table><tr><td></td><td>Unst. est.</td><td>SE</td><td>St. est.</td><td>CR</td></tr><tr><td>Harsh discipline</td><td></td><td></td><td></td><td></td></tr><tr><td> Physical discipline</td><td>1.37</td><td>0.30</td><td>.82</td><td>4.63***</td></tr><tr><td> Emotional discipline</td><td>1.00</td><td>-</td><td>.70</td><td>-<... | <table><tr><td></td><td>Unst. est.</td><td>SE</td><td>St. est.</td><td>CR</td></tr><tr><td>Harsh discipline</td><td></td><td></td><td></td><td></td></tr><tr><td>Physical discipline</td><td>1.37</td><td>0.30</td><td>.82</td><td>4.63***</td></tr><tr><td>Emotional discipline</td><td>1.00</td><td>-</td><td>.70</td><td>-</t... | <table><tr><td></td><td>Unst. est.</td><td>SE</td><td>St. est.</td><td>CR</td></tr><tr><td>Working memory</td><td></td><td></td><td></td><td></td></tr><tr><td>Harsh discipline</td><td>−2.23</td><td>2.19</td><td>-.08</td><td>−1.02</td></tr><tr><td>Block-Tapping test forward</td><td>1.00</td><td>-</td><td>.83</td><td>-</... |
91326b9116c5cc09fa811f8c7d2ae9389b954a8f93e81ad2b9165ff623cc9567.png | simple | <table><tr><td>Factor</td><td>Chi-square</td><td>Significance</td></tr><tr><td>Female sex</td><td>255.97</td><td><i>p.</i> < 0.01</td></tr><tr><td>Family history of osteoporosis</td><td>3.11</td><td><i>p.</i> < 0.01</td></tr><tr><td>Previous fracture</td><td>1.51</td><td><i>p.</i> < 0.01</td></tr><tr><td>Under... | <table><tr><td>Factor</td><td>Chi-square</td><td>Significance</td></tr><tr><td>Female sex</td><td>255.97</td><td>p. < 0.01</td></tr><tr><td>Family history of osteoporosis</td><td>3.11</td><td>p. < 0.01</td></tr><tr><td>Previous fracture</td><td>1.51</td><td>p. < 0.01</td></tr><tr><td>Underweight</td><td>20.04</td><td>p... | <table><tr><td>Rheumatoid Arthritis</td><td>2.86</td><td>ns</td></tr><tr><td>Nephrolithiasis*</td><td>3.00</td><td>ns</td></tr><tr><td>Thyroid*</td><td>3.85</td><td>ns</td></tr><tr><td>Early menopause</td><td>47.36</td><td>p. < 0.01</td></tr><tr><td>Amenorrhea > 12 months</td><td>0.15</td><td>ns</td></tr><tr><td>Ovarie... |
379b5f94db1c31e0fa8be5d4d091f227d48b9b4b9c09b98ac8ddc84702d54d78.png | simple | <table><tr><td></td><td>Telencephalon</td><td>Opctic tecta</td><td>Cerebellum</td><td>Medulla</td><td>Hypothalamus</td></tr><tr><td>Olfactory bulbs</td><td>1.06</td><td>1.02</td><td>1.23</td><td>1.15</td><td>1.04</td></tr><tr><td>Telencephalon</td><td></td><td>0.96</td><td>1.16</td><td>1.08</td><td>0.98</td></tr><tr><t... | <table><tr><td></td></tr><tr><td>Olfactory bulbs</td></tr><tr><td>Telencephalon</td></tr><tr><td>Optic tecta</td></tr><tr><td>Cerebellum</td></tr><tr><td>Medulla</td></tr></table> | <table><tr><td>Telencephalon</td><td>Opctic tecta</td><td>Cerebellum</td><td>Medulla</td><td>Hypothalamus</td></tr><tr><td>1.06</td><td>1.02</td><td>1.23</td><td>1.15</td><td>1.04</td></tr><tr><td></td><td>0.96</td><td>1.16</td><td>1.08</td><td>0.98</td></tr><tr><td></td><td></td><td>1.21</td><td>1.13</td><td>1.03</td>... |
021e1dc7b113b15d59fe03c49b03d16cc4f0962e0480874cc3fe5859518b914b.png | simple | <table><tr><td>Hospital characteristic</td><td>All hospitals (<i>n </i>= 51)</td><td>Score 0 to 6 (<i>n </i>= 17)</td><td>Score 7 to 8 (<i>n </i>= 9)</td><td>Score 9 to 14 (<i>n </i>= 16)</td><td>Score 15 to 19 (<i>n </i>= 9)</td></tr><tr><td>Number of hospital beds</td><td>107 (44 to 198)</td><td>33 (21 to 69)</td><td... | <table><tr><td>Hospital characteristic</td><td>All hospitals (n = 51)</td><td>Score 0 to 6 (n = 17)</td><td>Score 7 to 8 (n = 9)</td><td>Score 9 to 14 (n = 16)</td><td>Score 15 to 19 (n = 9)</td></tr><tr><td>Number of hospital beds</td><td>107 (44 to 198)</td><td>33 (21 to 69)</td><td>143 (101 to 198)</td><td>122 (96 t... | <table><tr><td>Hospital characteristic</td><td>All hospitals (n = 51)</td><td>Score 0 to 6 (n = 17)</td><td>Score 7 to 8 (n = 9)</td><td>Score 9 to 14 (n = 16)</td><td>Score 15 to 19 (n = 9)</td></tr><tr><td> of ICU days 2009</td><td>03)</td><td> (630 to 3,772)</td><td>4 to 4,784)</td><td>0)</td><td>,623 (8,219 to 31,7... |
274693e8292470571eb9ff81a07016f9efe368298038c365563b5d9d7678154f.png | simple | <table><tr><td>Variable</td><td>Odds ratio</td><td>95% confidence interval</td></tr><tr><td><i>Sex</i></td><td></td><td></td></tr><tr><td> Male</td><td>1.00</td><td>—</td></tr><tr><td> Female</td><td>2.93</td><td>1.29–6.67</td></tr><tr><td><i>Posttest HIV counselling</i></td><td></td><td></td></tr><tr><td> ... | <table><tr><td>Variable</td><td>Odds ratio</td><td>95% confidence interval</td></tr><tr><td>Sex</td><td></td><td></td></tr></table> | <table><tr><td>Male</td><td>1.00</td><td>—</td></tr><tr><td>Female</td><td>2.93</td><td>1.29–6.67</td></tr><tr><td>Posttest HIV counselling</td><td></td><td></td></tr><tr><td>No</td><td>1.00</td><td>—</td></tr><tr><td>Yes</td><td>2.96</td><td>1.22–7.19</td></tr><tr><td>Used contraception to prevent risk of transmission... |
ab4e0e0c343521e66246bd69fce50adf92589cb63346ff41777be84c42187d04.png | complex | <table><tr><td></td><td colspan="2">European Americans</td><td colspan="2">African Americans</td><td colspan="2">Mexican Americans</td></tr><tr><td></td><td>With noise (%)</td><td>Denoised (%)</td><td>With noise (%)</td><td>Denoised (%)</td><td>With noise (%)</td><td>Denoised (%)</td></tr><tr><td>Europe</td><td>100</td... | <table><tr><td></td><td colspan="2">European Americans</td><td>African Americans</td></tr><tr><td></td><td>With noise (%)</td><td>Denoised (%)</td><td>With noise (%)</td></tr><tr><td>Europe</td><td>100</td><td>100</td><td>97</td></tr><tr><td>Africa</td><td>1</td><td>0</td><td>99</td></tr><tr><td>America</td><td>29</td>... | <table><tr><td>African Americans</td><td colspan="2">Mexican Americans</td></tr><tr><td>Denoised (%)</td><td>With noise (%)</td><td>Denoised (%)</td></tr><tr><td>94</td><td>100</td><td>98</td></tr><tr><td>99</td><td>91</td><td>80</td></tr><tr><td>10</td><td>100</td><td>100</td></tr><tr><td>4</td><td>76</td><td>27</td><... |
c7187518d558522f9053148df4a8cd6169f5d304b0552ed0edff872fc6c2bba0.png | simple | <table><tr><td></td><td>MM mean (SD)</td><td>PA mean (SD)</td><td>Comparison mean (SD)</td><td>Statistics</td><td>Paired Comparisons*</td></tr><tr><td>MANCOVA</td><td></td><td></td><td></td><td>Multivariate Test: Wilk's λ (6, 110) = .754; <i>p </i>< 0.015</td><td></td></tr><tr><td>Composite MCMI</td><td>385.22 ... | <table><tr><td></td><td>MM mean (SD)</td><td>PA mean (SD)</td><td>Comparison mean (SD)</td><td>Statistics</td><td>Paired Comparisons*</td></tr><tr><td>MANCOVA</td><td></td><td></td><td></td><td>Multivariate Test: Wilk's λ (6, 110) = .754; p < 0.015</td><td></td></tr><tr><td>Composite MCMI</td><td>385.22 (136.66)</td><t... | <table><tr><td>Cluster C</td><td>137.94 (45.94)</td><td>136.50 (40.16)</td><td>87.78 (21.75)</td><td>Univariate F = 4.28, df = 2, p = 0.019</td><td>A, B</td></tr></table> |
66c9690286fe97cca05cbd19ced191fe94b571a3eceec8f176a99566273cd442.png | simple | <table><tr><td><i>f</i></td><td>1/2</td><td>5/8</td><td>3/4</td><td>7/8</td><td>1</td></tr><tr><td>model A: simple</td><td>69</td><td>59</td><td>47</td><td>32</td><td>16</td></tr><tr><td>model B: treated class</td><td>62</td><td>53</td><td>42</td><td>31</td><td>19</td></tr><tr><td>model C: day care</td><td>80</td><td>7... | <table><tr><td>f</td><td>1/2</td><td>5/8</td><td>3/4</td><td>7/8</td><td>1</td></tr><tr><td>model A: simple</td><td>69</td><td>59</td><td>47</td><td>32</td><td>16</td></tr><tr><td>model B: treated class</td><td>62</td><td>53</td><td>42</td><td>31</td><td>19</td></tr><tr><td>model C: day care</td><td>80</td><td>73</td><... | <table><tr><td>f</td><td>1/2</td><td>5/8</td><td>3/4</td><td>7/8</td><td>1</td></tr><tr><td>ransmission</td><td>79</td><td>1</td><td>61</td><td>7</td><td>9</td></tr></table> |
88bad5d44aee0a8df05b0af63ed0996cd12a4e9afdf78244061a4a2e217c8e89.png | simple | <table><tr><td></td><td>WT-NFD</td><td><i>Pr2x<sub>7</sub></i><sup>−/−</sup>-NFD</td><td>WT-HFD</td><td><i>Pr2x<sub>7</sub></i><sup>−/−</sup>-HFD</td></tr><tr><td>Body weight, g</td><td>31.8 ± 2.3</td><td>32.6 ± 1.9</td><td>41.2 ± 5.5<sup>∗</sup></td><td>40.6 ± 1.5<sup>... | <table><tr><td></td><td>WT-NFD</td><td>Pr2x7−/−-NFD</td><td>WT-HFD</td><td>Pr2x7−/−-HFD</td></tr><tr><td>Body weight, g</td><td>31.8 ± 2.3</td><td>32.6 ± 1.9</td><td>41.2 ± 5.5∗</td><td>40.6 ± 1.5∗</td></tr><tr><td>Glucose, mmol·l−1</td><td>5.56 ± 0.88</td><td>5.63 ± 0.73</td><td>9.01 ± 0.71∗</td><td>8.85 ± 1.08∗</td><... | <table><tr><td></td><td>WT-NFD</td><td>Pr2x7−/−-NFD</td><td>WT-HFD</td><td>Pr2x7−/−-HFD</td></tr><tr><td>Insulin, pmol·l−1</td><td>63.9 ± 18.7</td><td>58.3 ± 11.5</td><td>158.1 ± 18.1∗</td><td>151.9 ± 19.1∗</td></tr><tr><td>HOMA-IR</td><td>2.21 ± 0.79</td><td>2.05 ± 0.56</td><td>8.84 ± 1.32∗</td><td>8.38 ± 1.86∗</td></... |
218257c7644cc4f82fe59d7c5c9805240909be14fcc798798c6afc935146254d.png | complex | <table><tr><td>Treatment</td><td>Dose (mg/kg)</td><td colspan="9">Reversibility study</td></tr><tr><td> </td><td> </td><td>Liver</td><td>Kidney</td><td>Lungs</td><td>Heart</td><td>Testes</td><td>Spleen</td><td>Pancreas</td><td>Brain</td><td>Ovaries</td></tr><tr><td>Distilled water</td><td>(10 ml/kg)</td><td>2.60 ±... | <table><tr><td>Treatment</td><td>Dose (mg/kg)</td><td colspan="9">Reversibility study</td></tr><tr><td></td><td></td><td>Liver</td><td>Kidney</td><td>Lungs</td><td>Heart</td><td>Testes</td><td>Spleen</td><td>Pancreas</td><td>Brain</td><td>Ovaries</td></tr><tr><td>Distilled water</td><td>(10 ml/kg)</td><td>2.60 ± 0.11</... | <table><tr><td>DAS-77</td><td>400</td><td>2.74 ± 0.12</td><td>0.62 ± 0.01</td><td>0.88 ± 0.0*</td><td>0.42 ± 0.03</td><td>0.95 ± 0.27</td><td>0.25 ± 0.01</td><td>0.26 ± 0.02</td><td>0.71 ± 0.04</td><td>0.12 ± 0.01</td></tr><tr><td>DAS-77</td><td>2000</td><td>2.79 ± 0.10</td><td>0.63 ± 0.05</td><td>0.83 ± 0.02</td><td>0... |
64f21d32d774243c1f2b72d529b76b6dc3e98afe4369ae310c2021e3a3d8ff41.png | simple | <table><tr><td></td><td>Baseline</td><td>Week 12</td><td>Percentage change (%)#</td><td>Baseline vs. week 12 p-value</td></tr><tr><td>hsCRP [mg/dL]</td><td></td><td></td><td></td><td></td></tr><tr><td>PTV</td><td>0.17 ± 0.2</td><td>0.14 ± 0.21</td><td>−28.6 ± 157.4</td><td>0.08</td></tr><tr><td>ATV... | <table><tr><td></td><td>Baseline</td><td>Week 12</td><td>Percentage change (%)#</td><td>Baseline vs. week 12 p-value</td></tr><tr><td>hsCRP [mg/dL]</td><td></td><td></td><td></td><td></td></tr><tr><td>PTV</td><td>0.17 ± 0.2</td><td>0.14 ± 0.21</td><td>−28.6 ± 157.4</td><td>0.08</td></tr><tr><td>ATV</td><td>0.33 ± 1.1</... | <table><tr><td></td><td>Baseline</td><td>Week 12</td><td>Percentage change (%)#</td><td>Baseline vs. week 12 p-value</td></tr><tr><td>ATV</td><td>36.8 ± 27.5</td><td>37. ± 27.1</td><td>6.2 ± 32.3</td><td>0.05</td></tr><tr><td>Total bilirubin [mg/dL]**</td><td></td><td></td><td></td><td></td></tr><tr><td>PTV</td><td>0.8... |
e3638c1cc3311358c2d4390f6a29d13d4e9b72a6c9b474024e8c1f3b1d01ffa6.png | complex | <table><tr><td rowspan="2">Variables</td><td colspan="3">PITC acceptance status</td></tr><tr><td>Yes (%)</td><td>No (%)</td><td>Total (%)</td></tr><tr><td colspan="4"><i>Age</i></td></tr><tr><td>≤19</td><td>85 (81.7)</td><td>19 (18.3)</td><td>104 (26.9)</td></tr><tr><td>20–29</td><td>181 (81.9)</td><td>40 (... | <table><tr><td rowspan="2">Variables</td><td>PITC acceptance status</td></tr><tr><td>Yes (%)</td></tr><tr><td colspan="2">Age</td></tr><tr><td>≤19</td><td>85 (81.7)</td></tr><tr><td>20–29</td><td>181 (81.9)</td></tr><tr><td>30–45</td><td>46 (75.4)</td></tr><tr><td colspan="2">Residence</td></tr><tr><td>Urban</td><td>23... | <table><tr><td colspan="2">PITC acceptance status</td></tr><tr><td>No (%)</td><td>Total (%)</td></tr><tr><td colspan="2">Age</td></tr><tr><td>19 (18.3)</td><td>104 (26.9)</td></tr><tr><td>40 (18.1)</td><td>221 (57.3)</td></tr><tr><td>15 (24.6)</td><td>61 (15.8)</td></tr><tr><td colspan="2">Residence</td></tr><tr><td>63... |
4a7a4b94daf7d1ae874dfbe928d8199d1969ada52ebaf0368494d9794069908a.png | simple | <table><tr><td>Week</td><td>Direct heritability</td><td>Indirect heritability</td><td>Total heritability</td></tr><tr><td>1</td><td>0.17 (0.03)</td><td>0.44 (0.13)</td><td>0.19 (0.10)</td></tr><tr><td>2</td><td>0.24 (0.03)</td><td>0.23 (0.07)</td><td>0.09 (0.06)</td></tr><tr><td>3</td><td>0.22 (0.02)</td><td>0.18 (0.06... | <table><tr><td>Week</td><td>Direct heritability</td><td>Indirect heritability</td><td>Total heritability</td></tr><tr><td>1</td><td>0.17 (0.03)</td><td>0.44 (0.13)</td><td>0.19 (0.10)</td></tr></table> | <table><tr><td>Week</td><td>Direct heritability</td><td>Indirect heritability</td><td>Total heritability</td></tr><tr><td>2</td><td>0.24 (0.03)</td><td>0.23 (0.07)</td><td>0.09 (0.06)</td></tr><tr><td>3</td><td>0.22 (0.02)</td><td>0.18 (0.06)</td><td>0.05 (0.04)</td></tr><tr><td>4</td><td>0.15 (0.02)</td><td>0.16 (0.06... |
bda3d96d1ee86f0be6de2a803ba7cc883404a299cae1701e1aef27ebc326f7c6.png | complex | <table><tr><td rowspan="2">Principle parameter</td><td> </td><td colspan="3">EACM</td><td colspan="3">EAC</td></tr><tr><td> </td><td>Case number</td><td>Eradication rate (%)</td><td><i>P</i> value</td><td>Case number</td><td>Eradication rate (%)</td><td><i>P</i> value</td></tr><tr><td rowspan="2">Age</td><td><60 yea... | <table><tr><td rowspan="2">Principle parameter</td><td></td><td colspan="3">EACM</td><td colspan="3">EAC</td></tr><tr><td></td><td>Case number</td><td>Eradication rate (%)</td><td>P value</td><td>Case number</td><td>Eradication rate (%)</td><td>P value</td></tr><tr><td rowspan="2">Age</td><td><60 years</td><td>75/78</t... | <table><tr><td rowspan="2">Alcohol consumption</td><td>(−)</td><td>69/72</td><td>95.8</td><td rowspan="2">0.872</td><td>61/78</td><td>78.2</td><td rowspan="2">0.523</td></tr><tr><td>(+)</td><td>19/20</td><td>95.0</td><td>12/14</td><td>85.7</td></tr><tr><td rowspan="2">Previous history of peptic ulcer</td><td>(−)</td><t... |
dcabe4a54b77db44dd88712608d1a79410d4c0d427738621d39909f677241d59.png | simple | <table><tr><td>Amino acid</td><td>No. residues/100 residues</td></tr><tr><td>Arginine</td><td>7.12</td></tr><tr><td>Histidine</td><td>3.39</td></tr><tr><td>Isoleucine</td><td>3.76</td></tr><tr><td>Leucine</td><td>7.71</td></tr><tr><td>Lysine</td><td>9.18</td></tr><tr><td>Methionine</td><td>3.52</td></tr><tr><td>Phenyla... | <table><tr><td>Amino acid</td><td>No. residues/100 residues</td></tr><tr><td>Arginine</td><td>7.12</td></tr><tr><td>Histidine</td><td>3.39</td></tr></table> | <table><tr><td>Isoleucine</td><td>3.76</td></tr><tr><td>Leucine</td><td>7.71</td></tr><tr><td>Lysine</td><td>9.18</td></tr><tr><td>Methionine</td><td>3.52</td></tr><tr><td>Phenylalanine</td><td>4.46</td></tr><tr><td>Threonine</td><td>4.67</td></tr><tr><td>Tryptophan</td><td>0.19</td></tr><tr><td>Valine</td><td>5.17</td... |
9aba2cc0b39dd5bb0e2f748d9c4176882b4e514257b891fb0fe251e736b75cf9.png | simple | <table><tr><td>Anatomical region</td><td>BA</td><td><i>x</i></td><td><i>y</i></td><td><i>z</i></td><td><i>Z</i>-value</td><td>Extent</td></tr><tr><td>R lingual/paraH gyrus</td><td>19/30</td><td>18</td><td>−51</td><td>−3</td><td>5.03</td><td>109</td></tr><tr><td><i>R lingual gyrus</i></td><td><i>19</i></td><... | <table><tr><td>Anatomical region</td><td>BA</td><td>x</td><td>y</td><td>z</td><td>Z-value</td><td>Extent</td></tr><tr><td>R lingual/paraH gyrus</td><td>19/30</td><td>18</td><td>−51</td><td>−3</td><td>5.03</td><td>109</td></tr><tr><td>R lingual gyrus</td><td>19</td><td>18</td><td>−59</td><td>−5</td><td>3.54</td><td></td... | <table><tr><td>Anatomical region</td><td>BA</td><td>x</td><td>y</td><td>z</td><td>Z-value</td><td>Extent</td></tr><tr><td></td><td></td><td></td><td></td><td>42</td><td>3.33</td><td></td></tr><tr><td>L MTG/angular g./TPJ</td><td>39</td><td>−34</td><td>−65</td><td>29</td><td>3.71</td><td>22</td></tr><tr><td>L IPL/angula... |
4de968997c5b657d8107a6441c33742876f131a8f197c2d684afb82369dc2160.png | simple | <table><tr><td>Dataset</td><td>Number of sequences</td></tr><tr><td>GATA1</td><td>14,351</td></tr><tr><td>SOX2</td><td>4526</td></tr><tr><td>OCT4</td><td>3761</td></tr><tr><td>STAT3</td><td>2546</td></tr><tr><td>KLF1</td><td>945</td></tr></table> | <table><tr><td>Dataset</td><td>Number of sequences</td></tr><tr><td>GATA1</td><td>14,351</td></tr><tr><td>SOX2</td><td>4526</td></tr></table> | <table><tr><td>Dataset</td><td>Number of sequences</td></tr><tr><td>OCT4</td><td>3761</td></tr><tr><td>STAT3</td><td>2546</td></tr><tr><td>KLF1</td><td>945</td></tr></table> |
d586b84a8fd2beb5e0fbc7a5dc725136fdbd9aaaefb954f8c1a2a42afba47a8b.png | simple | <table><tr><td>Locations of lesion</td><td>Group 1</td><td>Group 2</td><td><i>p</i> value</td></tr><tr><td>RIV</td><td>(1/1) 100.00%</td><td>(2/2) 100.00%</td><td>-</td></tr><tr><td>RSCV</td><td>(0/0) 0.00%</td><td>(2/2) 100.00%</td><td>-</td></tr><tr><td>SVC</td><td>(1/1) 100.00%</td><td>(3/3) 100.00%</td><td>-</td></... | <table><tr><td>Locations of lesion</td><td>Group 1</td><td>Group 2</td><td>p value</td></tr><tr><td>RIV</td><td>(1/1) 100.00%</td><td>(2/2) 100.00%</td><td>-</td></tr><tr><td>RSCV</td><td>(0/0) 0.00%</td><td>(2/2) 100.00%</td><td>-</td></tr><tr><td>SVC</td><td>(1/1) 100.00%</td><td>(3/3) 100.00%</td><td>-</td></tr><tr>... | <table><tr><td>Locations of lesion</td><td>Group 1</td><td>Group 2</td><td>p value</td></tr><tr><td>LSCV</td><td>(1/1) 100.00%</td><td>(2/2) 100.00%</td><td>-</td></tr><tr><td>LIV + SVC</td><td>(1/2) 50.00%</td><td>(3/3) 100.00%</td><td>0.171</td></tr><tr><td>LSCV + LIV</td><td>(2/3) 66.67%</td><td>(2/3) 66.67%</td><td... |
72bba1eb0b19251bab71fe06a7b3dae5c6c6e7cc45c5ea4069889c10c25c832e.png | simple | <table><tr><td>Variables</td><td>Group 1 ISH positive<i>N</i> = 10</td><td>Group 2 ISH negative <i>N</i> = 15</td><td><i>P</i></td></tr><tr><td>Patient age at LT</td><td>49 ±11</td><td>52 ±11</td><td>.66</td></tr><tr><td>Female gender (patient)</td><td>40%</td><td>13%</td><td>.13</td></tr><tr><td>Caucasian (p... | <table><tr><td>Variables</td><td>Group 1 ISH positiveN = 10</td><td>Group 2 ISH negative N = 15</td><td>P</td></tr><tr><td>Patient age at LT</td><td>49 ±11</td><td>52 ±11</td><td>.66</td></tr><tr><td>Female gender (patient)</td><td>40%</td><td>13%</td><td>.13</td></tr><tr><td>Caucasian (patient)</td><td>90%</td><td>87%... | <table><tr><td>Cold ischemia time, hours</td><td>7 ±2</td><td>7 ±2</td><td>.74</td></tr><tr><td>Warm ischemia time, minutes</td><td>39 ±9</td><td>34 ±10</td><td>.28</td></tr><tr><td>Tacrolimus as primary immune suppressant</td><td>100%</td><td>83%</td><td>.23</td></tr><tr><td>Steroid bolus treated ACR</td><td>30%</td><... |
cc720abf801c4ad19a97890155910db8f73c3cf3b72d8cf23cfdd4d8686aabb6.png | simple | <table><tr><td>S1</td><td>S2</td><td>S3</td><td>S4</td><td>Id</td><td>Neuro-Fuzzy output</td></tr><tr><td>6752</td><td>6664</td><td>6577</td><td>6490</td><td>0</td><td>0.7655</td></tr><tr><td>6664</td><td>6577</td><td>6490</td><td>6404</td><td>0</td><td>0.7383</td></tr><tr><td>6577</td><td>6490</td><td>6404</td><td>632... | <table><tr><td>S1</td><td>S2</td><td>S3</td></tr><tr><td>6752</td><td>6664</td><td>6577</td></tr><tr><td>6664</td><td>6577</td><td>6490</td></tr><tr><td>6577</td><td>6490</td><td>6404</td></tr><tr><td>6490</td><td>6404</td><td>6320</td></tr><tr><td>6404</td><td>6320</td><td>6236</td></tr><tr><td>6320</td><td>6236</td><... | <table><tr><td>S4</td><td>Id</td><td>Neuro-Fuzzy output</td></tr><tr><td>6490</td><td>0</td><td>0.7655</td></tr><tr><td>6404</td><td>0</td><td>0.7383</td></tr><tr><td>6320</td><td>0</td><td>0.7004</td></tr><tr><td>6236</td><td>0</td><td>0.6653</td></tr><tr><td>6153</td><td>0</td><td>0.6348</td></tr><tr><td>6072</td><td... |
ab5dc640cc291606a1ea5079c86a2eb8b8d2139e022ff75c75aa474fceb0a020.png | simple | <table><tr><td>Experiment</td><td>∆6</td><td>REG19</td><td>TS01</td></tr><tr><td>1</td><td>0</td><td>11</td><td>120</td></tr><tr><td>2</td><td>0</td><td>64</td><td>714</td></tr><tr><td>3</td><td>4</td><td>111</td><td>445</td></tr><tr><td>4</td><td>no data</td><td>no data</td><td>599</td></tr><tr><td>average</td><... | <table><tr><td>Experiment</td><td>∆6</td><td>REG19</td><td>TS01</td></tr><tr><td>1</td><td>0</td><td>11</td><td>120</td></tr><tr><td>2</td><td>0</td><td>64</td><td>714</td></tr><tr><td>3</td><td>4</td><td>111</td><td>445</td></tr><tr><td>4</td><td>no data</td><td>no data</td><td>599</td></tr></table> | <table><tr><td>Experiment</td><td>∆6</td><td>REG19</td><td>TS01</td></tr><tr><td>average</td><td>133</td><td>6200</td><td>42,633</td></tr></table> |
7a305957c237f40b9d474a21d6326946e8b40014c0be569fbe56108cf1fa393f.png | complex | <table><tr><td></td><td colspan="5">Males</td><td colspan="5">Females</td></tr><tr><td></td><td>% (n/N)</td><td>PR<sup>b</sup></td><td>95% CI</td><td>PR<sup>c</sup></td><td>95% CI</td><td>% (n/N)</td><td>PR<sup>c</sup></td><td>95% CI</td><td>PR<sup>b</sup></td><td>95% CI</td></tr><tr><td>Baseline</td><td></td><td></td>... | <table><tr><td></td><td colspan="5">Males</td></tr><tr><td></td><td>% (n/N)</td><td>PRb</td><td>95% CI</td><td>PRc</td><td>95% CI</td></tr><tr><td>Baseline</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Overweight/Obese</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Primary School</td><td>... | <table><tr><td colspan="5">Females</td></tr><tr><td>% (n/N)</td><td>PRc</td><td>95% CI</td><td>PRb</td><td>95% CI</td></tr><tr><td></td><td></td><td></td><td></td><td></td></tr><tr><td></td><td></td><td></td><td></td><td></td></tr><tr><td></td><td></td><td></td><td></td><td></td></tr><tr><td>12 (48/417)</td><td>1.0</td... |
b501ebdef2767bed84269a60bb87ec1e6305435b9e044001023380998e6a777e.png | complex | <table><tr><td>Pin</td><td>I/O Attached</td><td>Action</td><td>States</td></tr><tr><td>L0</td><td>Red LED</td><td>move</td><td rowspan="2"></td></tr><tr><td>L1</td><td>Green LED</td><td>turn</td></tr><tr><td>L2</td><td>Orange LED</td><td rowspan="6"></td><td>gripper is open</td></tr><tr><td>L4</td><td>Yellow LED</td><t... | <table><tr><td>Pin</td><td>I/O Attached</td><td>Action</td><td>States</td></tr><tr><td>L0</td><td>Red LED</td><td>move</td><td rowspan="2"></td></tr><tr><td>L1</td><td>Green LED</td><td>turn</td></tr><tr><td>L2</td><td>Orange LED</td><td rowspan="4"></td><td>gripper is open</td></tr><tr><td>L4</td><td>Yellow LED</td><t... | <table><tr><td>5</td><td>h B</td><td rowspan="3"></td><td></td></tr><tr><td>L6</td><td>Switch C</td><td>see bottle</td></tr><tr><td>L7</td><td>Switch D</td><td>over drop</td></tr></table> |
a4a3adb75523e8ff18384e4b3647b2397bb82afe83357bc77ba320f05b56457b.png | complex | <table><tr><td></td><td>12-15 weeks old</td><td colspan="2">Symptomatic</td></tr><tr><td></td><td>WT</td><td>SOD1a</td><td>SOD1b</td></tr><tr><td>n (fiber, mice)</td><td>30, 11</td><td>19, 8</td><td>20, 10</td></tr><tr><td>Males</td><td>17, 5</td><td>11, 4</td><td>10, 5</td></tr><tr><td>Females</td><td>13, 6</td><td>8,... | <table><tr><td></td><td>12-15 weeks old</td><td colspan="2">Symptomatic</td></tr><tr><td></td><td>WT</td><td>SOD1a</td><td>SOD1b</td></tr><tr><td>n (fiber, mice)</td><td>30, 11</td><td>19, 8</td><td>20, 10</td></tr><tr><td>Males</td><td>17, 5</td><td>11, 4</td><td>10, 5</td></tr><tr><td>Females</td><td>13, 6</td><td>8,... | <table><tr><td></td><td>12-15 weeks old</td><td colspan="2">Symptomatic</td></tr><tr><td></td><td>WT</td><td>SOD1a</td><td>SOD1b</td></tr><tr><td>y-time(ms)</td><td>3.12 ± 0.14</td><td> ± 0.17</td><td>.28 ± 0.20</td></tr><tr><td>MEPPs frequency (s-1)</td><td>0.76 ± 0.11</td><td>0.61 ± 0.11</td><td>1.26 ± 0.33</td></tr>... |
8c874982ccec090933f3a88061cfc4ee3c49c2a1549f321e0ae5629eca3a87ec.png | simple | <table><tr><td></td><td>age (median, IQR)</td><td>Female sex (n)</td><td>FEV1 % predicted (median, IQR)</td><td>ICS dose, mcg/day (median, IQR)</td><td>Current smoker (n)</td></tr><tr><td>AKL1 – Placebo (n = 16)</td><td>41.00, 33.50 – 55.75</td><td>13</td><td>90.00, 79.75 – 115.50</td><td>1000, 400 &#... | <table><tr><td></td><td>age (median, IQR)</td><td>Female sex (n)</td><td>FEV1 % predicted (median, IQR)</td><td>ICS dose, mcg/day (median, IQR)</td><td>Current smoker (n)</td></tr><tr><td>AKL1 – Pla</td><td>41.00,</td><td>13</td><td>90.00, </td><td>1000, 400 – 2000</td><td></td></tr></table> | <table><tr><td>cebo (n = 16)</td><td> 33.50 – 55.75</td><td></td><td>79.75 – 115.50</td><td></td><td>1</td></tr><tr><td>Placebo – AKL1 (n = 16)</td><td>35.50, 29.50 – 55.50</td><td>12</td><td>85.50, 56.50 – 110.00</td><td>800, 400 – 1150</td><td>1</td></tr><tr><td>P value</td><td>0.67</td><td>0.67</td><td>0.25</td><td>... |
b6453d8303b875d376e3a69462464e67cacda1d154dfb7024ef0fceacee19eb0.png | complex | <table><tr><td>Ancestry</td><td>Parent</td><td colspan="3">Count</td><td colspan="3">Mean age</td></tr><tr><td></td><td></td><td>Alive</td><td>Dead</td><td>Total</td><td>Alive</td><td>Dead</td><td>All</td></tr><tr><td>African</td><td>Father</td><td>2435</td><td>6924</td><td>9359</td><td>72.4</td><td>70.4</td><td>70.9</... | <table><tr><td>Ancestry</td><td>Parent</td><td colspan="3">Count</td><td colspan="3">Mean age</td></tr><tr><td></td><td></td><td>Alive</td><td>Dead</td><td>Total</td><td>Alive</td><td>Dead</td><td>All</td></tr></table> | <table><tr><td>African</td><td>Father</td><td>2435</td><td>6924</td><td>9359</td><td>72.4</td><td>70.4</td><td>70.9</td></tr><tr><td>African</td><td>Mother</td><td>4185</td><td>5889</td><td>10,074</td><td>73.1</td><td>70.7</td><td>71.7</td></tr><tr><td>European</td><td>Father</td><td>113,611</td><td>178,017</td><td>291... |
ea0891e23289dcad8c8de4caed56a934aecffa1986150c4b968d2f2391f2dee1.png | simple | <table><tr><td>Pathway</td><td>miRNAs</td><td>Genes</td></tr><tr><td>MAPK signaling pathway</td><td>10</td><td>95</td></tr><tr><td>PI3K-Akt signaling pathway</td><td>9</td><td>106</td></tr><tr><td>Endocytosis</td><td>10</td><td>72</td></tr><tr><td>TGF-β signaling pathway</td><td>6</td><td>35</td></tr><tr><td>Wnt s... | <table><tr><td>Pathway</td><td>miRNAs</td><td>Genes</td></tr><tr><td>MAPK signaling pathway</td><td>10</td><td>95</td></tr></table> | <table><tr><td>Pathway</td><td>miRNAs</td><td>Genes</td></tr><tr><td>PI3K-Akt signaling pathway</td><td>9</td><td>106</td></tr><tr><td>Endocytosis</td><td>10</td><td>72</td></tr><tr><td>TGF-β signaling pathway</td><td>6</td><td>35</td></tr><tr><td>Wnt signaling pathway</td><td>9</td><td>58</td></tr><tr><td>Ubiquitin me... |
7861b35586050ca1ee3d1a7688495f559bc840e667e773328a2c4828782c6b65.png | simple | <table><tr><td>Gene</td><td>GeneBank accession number</td><td>Specific primer sequences (5’ to 3’)</td><td>Product size (bp)</td></tr><tr><td>αA-crystallin (<i>CRYAA</i>)</td><td>U05569</td><td>F: CGGGACAAGTTCGTCATCTT</td><td>203</td></tr><tr><td> </td><td> </td><td>R: GCAGACAGGGAGCAAGAGAG</td><td> </t... | <table><tr><td>Gene</td><td>GeneBank accession number</td><td>Specific primer sequences (5’ to 3’)</td><td>Product size (bp)</td></tr><tr><td>αA-crystallin (CRYAA)</td><td>U05569</td><td>F: CGGGACAAGTTCGTCATCTT</td><td>203</td></tr><tr><td></td><td></td><td>R: GCAGACAGGGAGCAAGAGAG</td><td></td></tr><tr><td>Heat-shock p... | <table><tr><td>Gene</td><td>GeneBank accession number</td><td>Specific primer sequences (5’ to 3’)</td><td>Product size (bp)</td></tr><tr><td>αB-crystallin (CRYAB)</td><td>NM001885.1</td><td>F: TCACCTAGCCACCATGGACATCGCCA</td><td>541</td></tr><tr><td></td><td></td><td>R: CAAAAGCTTATTACTATTTCTTGGGGG</td><td></td></tr><tr... |
db962b0d3961fa409205e8265399120f7a2f519dc9fecba0b755a3e15374d9dd.png | complex | <table><tr><td>Neuropsychological test</td><td colspan="2">Schizophrenics high SANS-score (S1)</td><td colspan="2">Schizophrenics low SANS-score (S2)</td><td colspan="2">Controls (C)</td><td></td><td colspan="3">Post-hoc analyses</td></tr><tr><td></td><td>Mean</td><td>SD</td><td>Mean</td><td>SD</td><td>Mean</td><td>SD<... | <table><tr><td>Neuropsychological test</td><td colspan="2">Schizophrenics high SANS-score (S1)</td><td colspan="2">Schizophrenics low SANS-score (S2)</td><td colspan="2">Controls (C)</td><td></td><td>Post-hoc analyses</td></tr><tr><td></td><td>Mean</td><td>SD</td><td>Mean</td><td>SD</td><td>Mean</td><td>SD</td><td>F-va... | <table><tr><td colspan="2">Post-hoc analyses</td></tr><tr><td>S2 vs. C*</td><td>S1 vs. C*</td></tr><tr><td>n.s.</td><td>p ≤0,01</td></tr><tr><td>n.s.</td><td>p ≤0,01</td></tr><tr><td>n.s.</td><td>n.s.</td></tr><tr><td>n.s.</td><td>p ≤0,01</td></tr><tr><td>n.s.</td><td>p ≤0,01</td></tr><tr><td>n.s.</td><td>p ≤0,01</td><... |
3d1358f85c4b2a1e0c34846813280003ac697eb5983f6c290d8422966203386d.png | complex | <table><tr><td></td><td colspan="4">Patients with diabetes</td><td colspan="4">Diabetes-free comparison group</td><td></td><td></td></tr><tr><td></td><td>Person-years</td><td>Cases</td><td>IR per 1000 person-years</td><td>95% CI</td><td>Person-years</td><td>Cases</td><td>IR per 1000 person-years</td><td>95% CI</td><td>... | <table><tr><td></td><td colspan="4">Patients with diabetes</td><td colspan="4">Diabetes-free comparison group</td><td></td><td></td></tr><tr><td></td><td>Person-years</td><td>Cases</td><td>IR per 1000 person-years</td><td>95% CI</td><td>Person-years</td><td>Cases</td><td>IR per 1000 person-years</td><td>95% CI</td><td>... | <table><tr><td>Age 80–84</td><td>12867.7</td><td>911</td><td>70.8</td><td>66.2–75.4</td><td>15319.3</td><td>601</td><td>39.2</td><td>36.1–42.4</td><td>1.8</td><td>1.6–2.0</td></tr><tr><td>Age 85–89</td><td>4836.9</td><td>403</td><td>83.3</td><td>75.2–91.5</td><td>5989.4</td><td>290</td><td>48.4</td><td>42.8–54.0</td><t... |
b20686f22edc8566254ac5636e6bd4ee8a6a1438ab6479aa0209430c77481cd7.png | complex | <table><tr><td rowspan="2">Microstructure analysis</td><td rowspan="2">Vehicle</td><td colspan="3">SB-742457</td></tr><tr><td>3.0 mg/kg</td><td>10 mg/kg</td><td>30 mg/kg</td></tr><tr><td>Number of licks</td><td>1456.7 (199.9)</td><td>992.8* (255.2)</td><td>1130.7 (249.9)</td><td>1238.9 (278.4)</td></tr><tr><td>Bout dur... | <table><tr><td rowspan="2">Microstructure analysis</td><td rowspan="2">Vehicle</td><td colspan="3">SB-742457</td></tr><tr><td>3.0 mg/kg</td><td>10 mg/kg</td><td>30 mg/kg</td></tr><tr><td>Number of licks</td><td>1456.7 (199.9)</td><td>992.8* (255.2)</td><td>1130.7 (249.9)</td><td>1238.9 (278.4)</td></tr><tr><td>Bout dur... | <table><tr><td>licks/s)</td><td>0.1)</td><td>2)</td><td>)</td><td> (0.1)</td></tr><tr><td>Latency (s)</td><td>84.7 (46.9)</td><td>66.1 (28.0)</td><td>76.1 (20.7)</td><td>62.7 (23.9)</td></tr></table> |
54b904f9bde9ba6ba282921f84e14405c74a0adeafd2e7d4a3b9123350a45e0a.png | complex | <table><tr><td>Characteristic</td><td>Doctors</td><td>Nurses</td></tr><tr><td colspan="3">Sex</td></tr><tr><td>Female</td><td>7</td><td>5</td></tr><tr><td>Male</td><td>8</td><td>0</td></tr><tr><td colspan="3">Age (years)</td></tr><tr><td>Mean</td><td>37</td><td>45</td></tr><tr><td>Range</td><td>26–53</td><td>38&#... | <table><tr><td>Characteristic</td><td>Doctors</td><td>Nurses</td></tr><tr><td colspan="3">Sex</td></tr><tr><td>Female</td><td>7</td><td>5</td></tr><tr><td>Male</td><td>8</td><td>0</td></tr><tr><td colspan="3">Age (years)</td></tr><tr><td>Mean</td><td>37</td><td>45</td></tr><tr><td>Range</td><td>26–53</td><td>38–53</td>... | <table><tr><td colspan="3">Years of practice in total</td></tr><tr><td>Mean</td><td>13</td><td>24</td></tr><tr><td>Range</td><td>1.75–29</td><td>16–33</td></tr><tr><td colspan="3">Years of practice in nephrology</td></tr><tr><td>Mean</td><td>9</td><td>20</td></tr><tr><td>Range</td><td>0.3–26</td><td>15–26</td></tr></ta... |
561d7f0fece6a967766a6cfaf3484a2c71a6f424b4dbc115454f2f3ed592a0ce.png | simple | <table><tr><td></td><td>Pre-Delphi questionnaire</td><td>Round 1</td><td>Round 2</td><td>Round 3</td></tr><tr><td>Consumers</td><td>16</td><td>13</td><td>13</td><td>9</td></tr><tr><td>Carers</td><td>3</td><td>2</td><td>0</td><td>0</td></tr><tr><td>Professionals</td><td>26</td><td>21</td><td>17</td><td>16</td></tr></tab... | <table><tr><td></td><td>Pre-Delphi questionnaire</td><td>Round 1</td><td>Round 2</td></tr><tr><td>Consumers</td><td>16</td><td>13</td><td>13</td></tr><tr><td>Carers</td><td>3</td><td>2</td><td>0</td></tr><tr><td>Professionals</td><td>26</td><td>21</td><td>17</td></tr></table> | <table><tr><td>Round 3</td></tr><tr><td>9</td></tr><tr><td>0</td></tr><tr><td>16</td></tr></table> |
91bf8d054e990a503398a2b2ea1912e031960eeebdfbfa64bd5152adf944f5f3.png | simple | <table><tr><td>Exposure</td><td>Cases (<i>n</i> = 2634)</td><td>Controls (<i>n</i> = 5074)</td><td>Crude OR (95%CI)</td><td>Adjusted OR† (95%CI)</td></tr><tr><td>Current use, <i>n</i> (%)</td><td></td><td></td><td></td><td></td></tr><tr><td>Conventional NSAIDs − PPIs</td><td>1599 (60.7)</td><td>3013 (59.4)<... | <table><tr><td>Exposure</td><td>Cases (n = 2634)</td><td>Controls (n = 5074)</td><td>Crude OR (95%CI)</td><td>Adjusted OR† (95%CI)</td></tr><tr><td>Current use, n (%)</td><td></td><td></td><td></td><td></td></tr><tr><td>Conventional NSAIDs − P</td><td>1599 (60.7)</td><td>3013 (59.</td><td></td><td></td></tr></table> | <table><tr><td>PIs</td><td></td><td>4)</td><td>1</td><td>1</td></tr><tr><td>Conventional NSAIDs + PPIs</td><td>775 (29.4)</td><td>1356 (26.7)</td><td>1.08 (0.97–1.20)</td><td>0.79 (0.68–0.92)*</td></tr><tr><td>Selective COX‐2 inhibitors − PPIs</td><td>179 (6.8)</td><td>487 (9.6)</td><td>0.69 (0.58–0.83)*</td><td>0.66 (... |
4d2c89d896cb1ab70dfd461bf2a41d1c711e1a30ae839efb9d4045d0808f725b.png | complex | <table><tr><td rowspan="2">Time</td><td colspan="2">50 Units, <i>n</i> = 9</td><td colspan="2">100 Units, <i>n</i> = 10</td><td colspan="2">200 Units, <i>n</i> = 10</td><td rowspan="2"><i>F</i> Statistic (d.f.) <sup>a</sup></td><td rowspan="2"><i>p</i>-Value</td></tr><tr><td>Mean, g</td><td>(SD)</td><td>Mean, g</td><td... | <table><tr><td rowspan="2">Time</td><td colspan="2">50 Units, n = 9</td><td colspan="2">100 Units, n = 10</td><td colspan="2">200 Units, n = 10</td><td rowspan="2">F Statistic (d.f.) a</td><td rowspan="2">p-Value</td></tr><tr><td>Mean, g</td><td>(SD)</td><td>Mean, g</td><td>(SD)</td><td>Mean, g</td><td>(SD)</td></tr><t... | <table><tr><td rowspan="2">Time</td><td colspan="2">50 Units, n = 9</td><td colspan="2">100 Units, n = 10</td><td colspan="2">200 Units, n = 10</td><td rowspan="2">F Statistic (d.f.) a</td><td rowspan="2">p-Value</td></tr><tr><td>Mean, g</td><td>(SD)</td><td>Mean, g</td><td>(SD)</td><td>Mean, g</td><td>(SD)</td></tr><t... |
56af3c3630ce634c56b6762f0b67f47955b303bd97307890f2b5555374f4b7bc.png | complex | <table><tr><td></td><td>Compound</td><td>Content (mg/g)</td></tr><tr><td rowspan="3"><i>Panax ginseng</i></td><td>Rb1</td><td>2.24</td></tr><tr><td>Re</td><td>1.13</td></tr><tr><td>Rg1</td><td>1.47</td></tr><tr><td rowspan="2"><i>Salvia miltiorrhiza</i></td><td>Salvianolia acid B</td><td>28.2</td></tr><tr><td>Tanshinon... | <table><tr><td></td><td>Compound</td><td>Content (mg/g)</td></tr><tr><td rowspan="3">Panax ginseng</td><td>Rb1</td><td>2.24</td></tr><tr><td>Re</td><td>1.13</td></tr><tr><td>Rg1</td><td>1.47</td></tr></table> | <table><tr><td></td><td>Compound</td><td>Content (mg/g)</td></tr><tr><td rowspan="2">Salvia miltiorrhiza</td><td>Salvianolia acid B</td><td>28.2</td></tr><tr><td>Tanshinone IIA</td><td>0.6</td></tr></table> |
a6490925a18905142c28e3eceb0c4b6af2c1198a988ad4ad95e4d95aaba41bc2.png | complex | <table><tr><td rowspan="2"> Age group</td><td rowspan="2">Sex</td><td colspan="4">Testosterone concentration (ng/mL)</td><td rowspan="2">Sex* group mean</td><td rowspan="2">Group mean</td><td rowspan="2">Sex mean</td></tr><tr><td>0.10</td><td>1</td><td>10</td><td>100</td></tr><tr><td rowspan="2">Group-I</td><td>Male</t... | <table><tr><td rowspan="2">Age group</td><td rowspan="2">Sex</td><td colspan="4">Testosterone concentration (ng/mL)</td><td rowspan="2">Sex* group mean</td><td rowspan="2">Group mean</td><td rowspan="2">Sex mean</td></tr><tr><td>0.10</td><td>1</td><td>10</td><td>100</td></tr><tr><td rowspan="2">Group-I</td><td>Male</td... | <table><tr><td>oup-III</td><td>Female</td><td>± 0.06</td><td></td><td> ± 0.05</td><td> ± 0.09</td><td> 0.03</td><td>± 0.017</td><td>0.01 (Female)</td></tr><tr><td colspan="2">Treatment mean</td><td>1.05 ± 0.02</td><td>1.05 ± 0.02</td><td>1.05 ± 0.02</td><td>1.00 ± 0.02</td><td></td><td colspan="2"></td></tr></table> |
74e8d687a77ff3a894517b6eb511246ea7d1dec2e7de96dffdea93b96bc4d19d.png | complex | <table><tr><td rowspan="2"></td><td>Entire cohort</td><td>PODXL neg</td><td>PODXL pos</td><td></td></tr><tr><td>n (%)</td><td>n (%)</td><td>n (%)</td><td><i>p-</i>value</td></tr><tr><td></td><td>171 (100.0)</td><td>29 (17.0)</td><td>142 (83.0)</td><td></td></tr><tr><td colspan="5">Age</td></tr><tr><td> ≤70</td><t... | <table><tr><td rowspan="2"></td><td>Entire cohort</td><td>PODXL neg</td><td>PODXL pos</td><td></td></tr><tr><td>n (%)</td><td>n (%)</td><td>n (%)</td><td>p-value</td></tr><tr><td></td><td>171 (100.0)</td><td>29 (17.0)</td><td>142 (83.0)</td><td></td></tr><tr><td colspan="5">Age</td></tr><tr><td>≤70</td><td>85 (49.7)</t... | <table><tr><td>Mixed</td><td>9 (5.3)</td><td>0 (0.0)</td><td>9 (6.3)</td><td rowspan="2">0.335</td></tr><tr><td>Diffuse</td><td>43 (25.1)</td><td>6 (20.7)</td><td>37 (26.1)</td></tr><tr><td colspan="5">Location</td></tr><tr><td>Esophagus + EG junction</td><td>106 (62.0)</td><td>15 (51.7)</td><td>91 (64.1)</td><td rowsp... |
1286252ff86f8b66923b2b9d28756b53bfc31c582ad97f25ee4f607518562722.png | complex | <table><tr><td>Characteristic</td><td>Non-IRABC</td><td>IRABC</td><td><i>P</i><sup>a</sup></td><td>OR<sup>b</sup></td><td>95% CI<sup>b</sup></td><td><i>P</i><sup>b</sup></td></tr><tr><td>Number</td><td>1060</td><td>580</td><td> </td><td> </td><td> </td><td> </td></tr><tr><td> Mean age ± SD<sup>c</sup></td><td>65.0... | <table><tr><td>Characteristic</td><td>Non-IRABC</td><td>IRABC</td><td>Pa</td><td>ORb</td></tr><tr><td>Number</td><td>1060</td><td>580</td><td></td><td></td></tr><tr><td>Mean age ± SDc</td><td>65.0 ± 20.2</td><td>70.0 ± 18.8</td><td><0.001</td><td></td></tr><tr><td>Age 65 and olderc</td><td>629 (61.1)</td><td>401 (71.9)... | <table><tr><td>95% CIb</td><td>Pb</td></tr><tr><td></td><td></td></tr><tr><td></td><td></td></tr><tr><td>1.122-1.912</td><td>0.005</td></tr><tr><td colspan="2">Specimen types</td></tr><tr><td>1.888-3.570</td><td><0.001</td></tr><tr><td></td><td>Reference</td></tr><tr><td>1.240-3.018</td><td>0.004</td></tr><tr><td>1.401... |
8113eb9ec8467397d1db33859cc544ba77ee967e03f87bfc8c2ce54cbb070e18.png | simple | <table><tr><td>Group</td><td>Mean fluorescence recovery rate(%,<i>x</i>±s) (t=4min)</td></tr><tr><td>BGC-823Cx43</td><td>35.6±0.9*</td></tr><tr><td>BGC-823Cx43T154A</td><td>12.1±0.6</td></tr><tr><td>BGC-823v</td><td>13.4±0.7</td></tr><tr><td>SGC-7901Cx43</td><td>39.4±0.8†</td></tr><tr><td... | <table><tr><td>Group</td><td>Mean fluorescence recovery rate(%,x±s) (t=4min)</td></tr><tr><td>BGC-823Cx43</td><td>35.6±0.9*</td></tr><tr><td>BGC-823Cx43T154A</td><td>12.1±0.6</td></tr></table> | <table><tr><td>Group</td><td>Mean fluorescence recovery rate(%,x±s) (t=4min)</td></tr><tr><td>BGC-823v</td><td>13.4±0.7</td></tr><tr><td>SGC-7901Cx43</td><td>39.4±0.8†</td></tr><tr><td>SGC-7901Cx43T154A</td><td>15.3±0.4</td></tr><tr><td>SGC-7901v</td><td>14.7±0.6</td></tr></table> |
1bd546dd39063e9fc729ae91860511bc7dd87a3974fb771b14e7243d2477fb62.png | complex | <table><tr><td></td><td>b</td><td>l-95 %</td><td>u-95 %</td><td>N<sub>eff</sub></td></tr><tr><td colspan="5">Dominance</td></tr><tr><td> Intercept</td><td>−0.30</td><td>−0.75</td><td>0.16</td><td>4000.00</td></tr><tr><td> <i>SS</i> vs. <i>LL</i> + <i>LS</i></td><td>0.05</td><td>−0.48</td><td>0.60</td>... | <table><tr><td></td><td>b</td></tr><tr><td colspan="2">Dominance</td></tr><tr><td>Intercept</td><td>−0.30</td></tr><tr><td>SS vs. LL + LS</td><td>0.05</td></tr><tr><td>Sex</td><td>0.70</td></tr><tr><td>SS vs. LL + LS × sex</td><td>−0.15</td></tr><tr><td colspan="2">Conscientiousness</td></tr><tr><td>Intercept</td><td>0... | <table><tr><td>l-95 %</td><td>u-95 %</td><td>Neff</td></tr><tr><td colspan="3">Dominance</td></tr><tr><td>−0.75</td><td>0.16</td><td>4000.00</td></tr><tr><td>−0.48</td><td>0.60</td><td>4000.00</td></tr><tr><td>−0.05</td><td>1.45</td><td>3812.24</td></tr><tr><td>−0.96</td><td>0.77</td><td>4000.00</td></tr><tr><td colspa... |
027a112a5cdbae7f5e93c2cc9f16532bc0b88d3000d94949fffece41765f8138.png | complex | <table><tr><td>Age (Years)</td><td>Gender</td><td>0</td><td>1</td><td>2</td><td>≥3</td><td>χ<sup>2</sup></td><td><i>p</i></td></tr><tr><td rowspan="2">60–69</td><td>Male</td><td> 30 (2.5)</td><td>1128 (62.1)</td><td>298 (61.6)</td><td>56 (45.5)</td><td rowspan="2">2933.719</td><td rowspan="2"><0.001... | <table><tr><td>Age (Years)</td><td>Gender</td><td>0</td><td>1</td><td>2</td><td>≥3</td><td>χ2</td><td>p</td></tr><tr><td rowspan="2">60–69</td><td>Male</td><td>30 (2.5)</td><td>1128 (62.1)</td><td>298 (61.6)</td><td>56 (45.5)</td><td rowspan="2">2933.719</td><td rowspan="2"><0.001</td></tr><tr><td>Female</td><td>1590 (... | <table><tr><td rowspan="2">70–79</td><td>Male</td><td>819 (68.3)</td><td>475 (26.2)</td><td>118 (24.4)</td><td>48 (39.0)</td><td rowspan="2">5.898</td><td rowspan="2">0.117</td></tr><tr><td>Female</td><td>846 (28.8)</td><td>497 (55.9)</td><td>122 (56.2)</td><td>28 (59.6)</td></tr><tr><td rowspan="2">80–89</td><td>Male<... |
62083e9d3416888c2a3c8194b76a66b2664e7666db0b4f58597308d7cc05d15b.png | complex | <table><tr><td rowspan="2"></td><td colspan="3">Categories of Infant Feeding Index</td><td rowspan="2"><i>p<sub>trend</sub></i></td></tr><tr><td>Poor</td><td>Medium</td><td>Good</td></tr><tr><td colspan="5">Acute upper respiratory infection</td></tr><tr><td>Two weeks prevalence (%)</td><td>31.7</td><td>25.5</td><td>20.... | <table><tr><td rowspan="2"></td><td colspan="3">Categories of Infant Feeding Index</td><td rowspan="2">ptrend</td></tr><tr><td>Poor</td><td>Medium</td><td>Good</td></tr><tr><td colspan="5">Acute upper</td></tr></table> | <table><tr><td rowspan="2"></td><td colspan="3">Categories of Infant Feeding Index</td><td rowspan="2">ptrend</td></tr><tr><td>Poor</td><td>Medium</td><td>Good</td></tr><tr><td colspan="5"> respiratory infection</td></tr><tr><td>Two weeks prevalence (%)</td><td>31.7</td><td>25.5</td><td>20.6</td><td>0.16 a</td></tr><tr... |
b9c4231ce8dde689e55b0491ec82a83c16e5001803d564d515f782b2c5a61220.png | complex | <table><tr><td></td><td></td><td colspan="3">Factor solution OLQ-13</td><td colspan="3">Factor solution OLQ-11</td></tr><tr><td>item</td><td>dim</td><td>1</td><td>2</td><td>3</td><td>1</td><td>2</td><td>3</td></tr><tr><td>A</td><td>Me</td><td>-</td><td>-</td><td>.408</td><td>-</td><td>-</td><td>.405</td></tr><tr><td>B<... | <table><tr><td></td><td></td><td colspan="3">Factor solution OLQ-13</td><td colspan="3">Factor solution OLQ-11</td></tr><tr><td>item</td><td>dim</td><td>1</td><td>2</td><td>3</td><td>1</td><td>2</td><td>3</td></tr><tr><td>A</td><td>Me</td><td>-</td><td>-</td><td>.408</td><td>-</td><td>-</td><td>.405</td></tr><tr><td>B<... | <table><tr><td></td><td></td><td colspan="3">Factor solution OLQ-13</td><td colspan="3">Factor solution OLQ-11</td></tr><tr><td>item</td><td>dim</td><td>1</td><td>2</td><td>3</td><td>1</td><td>2</td><td>3</td></tr><tr><td>C</td><td>a</td><td>-</td><td>0</td><td></td><td>-.150</td><td>69</td><td>-</td></tr><tr><td>D</td... |
cf94e4b25ba9400708a41bb5883708fe7e92c9dda2bc9d69d33c66de031a490c.png | complex | <table><tr><td>Parameter</td><td>Total (<i>N</i> = 193)</td></tr><tr><td colspan="2">Reason for last admission</td></tr><tr><td> Palliative procedure or surgery</td><td>28 (14.5)</td></tr><tr><td> Gastrointestinal symptoms</td><td>52 (26.9)</td></tr><tr><td> Cardiovascular or pulmonary symptoms</td><td>39 (20.2)</td></... | <table><tr><td>Parameter</td></tr><tr><td>Reason for last admission</td></tr><tr><td>Palliative procedure or surgery</td></tr><tr><td>Gastrointestinal symptoms</td></tr><tr><td>Cardiovascular or pulmonary symptoms</td></tr><tr><td>Infectious state</td></tr><tr><td>Uncontrolled pain</td></tr><tr><td>Hematologic instabil... | <table><tr><td>Total (N = 193)</td></tr><tr><td>Reason for last admission</td></tr><tr><td>28 (14.5)</td></tr><tr><td>52 (26.9)</td></tr><tr><td>39 (20.2)</td></tr><tr><td>31 (16.2)</td></tr><tr><td>11 (5.7)</td></tr><tr><td>12 (6.2)</td></tr><tr><td>7 (3.6)</td></tr><tr><td>13 (6.7)</td></tr><tr><td>23 (11.9)</td></tr... |
506fa1bd09eedff08385cf1e7e4e4448c8dd1516faf36211118a8279de0267c8.png | complex | <table><tr><td></td><td>DFS, <i>P</i> value</td><td>OS, <i>P</i> value</td></tr><tr><td></td><td>[HR (95 % CI)]</td><td>[HR (95 % CI)]</td></tr><tr><td colspan="3">Age (years)</td></tr><tr><td> <50</td><td>0.251</td><td>0.885</td></tr><tr><td> ≥50</td><td>0.678 (0.349–1.316)</td><td>0.938 (0.395–2.... | <table><tr><td></td><td>DFS, P value</td><td>OS, P value</td></tr><tr><td></td><td>[HR (95 % CI)]</td><td>[HR (95 % CI)]</td></tr><tr><td colspan="3">Age (years)</td></tr><tr><td><50</td><td>0.251</td><td>0.885</td></tr><tr><td>≥50</td><td>0.678 (0.349–1.316)</td><td>0.938 (0.395–2.228)</td></tr><tr><td colspan="3">Sex... | <table><tr><td></td><td>DFS, P value</td><td>OS, P value</td></tr><tr><td></td><td>[HR (95 % CI)]</td><td>[HR (95 % CI)]</td></tr><tr><td>≥10 mm</td><td>2.207 (1.080–4.510)</td><td>2.560 (0.991–6.613)</td></tr><tr><td>Cyfra 21-1 and CRP</td><td>0.019</td><td>0.235</td></tr><tr><td>Cyfra 21-1 < 3.3 ng/mL, CRP < 5 mg/L</... |
aa333dd96d6cd25d6ccf0bc9129f0ec9040d831dfa06d20da8758df623e3fa85.png | complex | <table><tr><td></td><td>Period Prevalence Per 100 000 (95% CI)</td><td>Incidence Per 100 000 (95% CI)</td></tr><tr><td>Overall</td><td>140.2 (100.1–179.2)</td><td>72.7 (52.5–91.8)</td></tr><tr><td colspan="3">Age, y</td></tr><tr><td>18–24</td><td>23.3 (16.7–29.8)</td><td>14.8 (10.6–18.8)</... | <table><tr><td></td><td>Period Prevalence Per 100 000 (95% CI)</td><td>Incidence Per 100 000 (95% CI)</td></tr><tr><td>Overall</td><td>140.2 (100.1–179.2)</td><td>72.7 (52.5–91.8)</td></tr><tr><td colspan="3">Age, y</td></tr><tr><td>18–24</td><td>23.3 (16.7–29.8)</td><td>14.8 (10.6–18.8)</td></tr><tr><td>25–44</td><td>... | <table><tr><td>No</td><td>123.6 (88.2–158.0)</td><td>66.4 (48.0–83.9)</td></tr><tr><td colspan="3">Hypertension</td></tr><tr><td>Yes</td><td>415.9 (294.2–534.9)</td><td>193.7 (138.6–46.5)</td></tr><tr><td>No</td><td>94.9 (68.1–120.7)</td><td>53.9 (39.1–67.8)</td></tr><tr><td colspan="3">Coronary heart disease</td></tr>... |
d0b8b556c90729722eca59c0dccd975807e001db08377c79878289fab1b7acc9.png | complex | <table><tr><td rowspan="2">Assembler</td><td colspan="5">Species assembled</td></tr><tr><td><i>A.hydrophila</i></td><td><i>B</i>.<i>cereus</i></td><td><i>B</i>.<i>fragilis</i></td><td><i>S</i>.<i>aureus</i></td><td><i>X</i>.<i>axonopodis</i></td></tr><tr><td>ABySS</td><td>237.5</td><td>48.3</td><td>146.2</td><td>73.9</... | <table><tr><td rowspan="2">Assembler</td><td colspan="5">Species assembled</td></tr><tr><td>A.hydrophila</td><td>B.cereus</td><td>B.fragilis</td><td>S.aureus</td><td>X.axonopodis</td></tr><tr><td>ABySS</td><td>237.5</td><td>48.3</td><td>146.2</td><td>73.9</td><td>89.9</td></tr><tr><td>CABOG</td><td>278.4</td><td>61.6</... | <table><tr><td rowspan="2">Assembler</td><td colspan="5">Species assembled</td></tr><tr><td>A.hydrophila</td><td>B.cereus</td><td>B.fragilis</td><td>S.aureus</td><td>X.axonopodis</td></tr><tr><td>SGA</td><td>68.8</td><td>23.4</td><td>41.2</td><td>38.1</td><td>47.8</td></tr><tr><td>SOAPdenovo</td><td>243.9</td><td>57.9<... |
7f2957e935079ac795da76636ea13389e77ef9a1121f58e7926600946847e026.png | complex | <table><tr><td>Groups</td><td>No smoker (n: 6742)</td><td>Ex-smoker (n: 976)</td><td>Cigarette smoking (n: 864)</td><td>Hookah smoking (n: 1067)</td><td>Cigarette and hookah (n: 41)</td><td><i>p</i> value</td></tr><tr><td>FBG<sup>1</sup> (mg/dl)</td><td>92.65 ± 38.71</td><td>96.78 ± 43.26</td><td>87.59 ±... | <table><tr><td>Groups</td><td>No smoker (n: 6742)</td><td>Ex-smoker (n: 976)</td><td>Cigarette smoking (n: 864)</td><td>Hookah smoking (n: 1067)</td><td>Cigarette and hookah (n: 41)</td><td>p value</td></tr><tr><td>FBG1 (mg/dl)</td><td>92.65 ± 38.71</td><td>96.78 ± 43.26</td><td>87.59 ± 33.86ab</td><td>93.60 ± 42.43c</... | <table><tr><td>hsCRP2 (mg/l)</td><td>1.62 (0.98–3.51)</td><td>1.55 (1–3.35)</td><td>1.71 (1.06–3.89)</td><td>1.63 (1.04–3.46)</td><td>2.02 (1.1–4.65)</td><td>< 0.001</td></tr></table> |
603223f0380bd6e30f2e263ba4a1e394275184bfc72a8e4370ec3a71f60aa3c5.png | simple | <table><tr><td>Element</td><td>Measurement</td></tr><tr><td>Ulna (NMMNH P-19460), length of semilunar notch</td><td>24.5*</td></tr><tr><td>Ulna (NMMNH P-19460), depth of semilunar notch</td><td>6.2*</td></tr><tr><td>Ulna (NMMNH P-19460), maximum mediolateral breadth</td><td>21.5</td></tr><tr><td>Radius (NMMNH P-19460),... | <table><tr><td>Element</td><td>Measurement</td></tr><tr><td>Ulna (NMMNH P-19460), length of semilunar notch</td><td>24.5*</td></tr><tr><td>Ulna (NMMNH P-19460), depth of semilunar notch</td><td>6.2*</td></tr><tr><td>Ulna (NMMNH P-19460), maximum mediolateral breadth</td><td>21.5</td></tr><tr><td>Radius (NMMNH P-19460),... | <table><tr><td>Element</td><td>Measurement</td></tr><tr><td>Metacarpal IV (NMMNH P-19640), distal breadth</td><td>9.9</td></tr><tr><td>Ungual (NMMNH P-19640), proximal breadth of most complete</td><td>8.6</td></tr></table> |
1e294ee02a36b2a266d54fa6adf11920e0622016a55582570719f3e00c498ad7.png | simple | <table><tr><td> </td><td>Media surveillance</td><td>Active surveillance</td><td>Total casualties</td></tr><tr><td> </td><td>Jan 08 –Sep 09</td><td>Oct 09 – Dec 11</td><td>N (% total)</td></tr><tr><td> </td><td>N (% total)</td><td>N (% total)</td><td> </td></tr><tr><td>Sex</td><td> </td><td> </td><td> </td><... | <table><tr><td></td><td>Media surveillance</td><td>Active surveillance</td><td>Total casualties</td></tr><tr><td></td><td>Jan 08 –S</td><td>Oct </td><td></td></tr></table> | <table><tr><td></td><td>ep 09</td><td>09 – Dec 11</td><td>N (% total)</td></tr><tr><td></td><td>N (% total)</td><td>N (% total)</td><td></td></tr><tr><td>Sex</td><td></td><td></td><td></td></tr><tr><td>Male</td><td>255 (78.0)</td><td>86 (78.2)</td><td>341 (78.0)</td></tr><tr><td>Female</td><td>60 (18.3)</td><td>24 (21.... |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.